Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 56 | 2023 | 1620 | 5.670 |
Why?
|
Cortical Spreading Depression | 42 | 2023 | 276 | 5.030 |
Why?
|
Trigeminal Nerve | 49 | 2019 | 249 | 3.890 |
Why?
|
Nitric Oxide Synthase | 51 | 2005 | 916 | 3.450 |
Why?
|
Migraine with Aura | 19 | 2022 | 203 | 3.430 |
Why?
|
Cerebrovascular Circulation | 95 | 2019 | 2731 | 3.360 |
Why?
|
Brain Ischemia | 85 | 2018 | 3265 | 3.110 |
Why?
|
Trigeminal Ganglion | 33 | 2012 | 186 | 2.090 |
Why?
|
Receptors, Serotonin | 23 | 2023 | 201 | 1.940 |
Why?
|
Dura Mater | 29 | 2023 | 291 | 1.920 |
Why?
|
Cerebral Infarction | 31 | 2015 | 1011 | 1.670 |
Why?
|
Meninges | 14 | 2023 | 190 | 1.630 |
Why?
|
Ischemic Attack, Transient | 27 | 2007 | 935 | 1.510 |
Why?
|
Pia Mater | 20 | 2005 | 88 | 1.470 |
Why?
|
Post-Traumatic Headache | 2 | 2021 | 74 | 1.390 |
Why?
|
Stroke | 44 | 2019 | 9981 | 1.360 |
Why?
|
Diagnosis-Related Groups | 21 | 2001 | 455 | 1.350 |
Why?
|
Calcitonin Gene-Related Peptide | 13 | 2023 | 306 | 1.300 |
Why?
|
Nitric Oxide | 31 | 2018 | 2132 | 1.280 |
Why?
|
Cerebrovascular Disorders | 19 | 2017 | 1504 | 1.260 |
Why?
|
Headache | 13 | 2023 | 1226 | 1.230 |
Why?
|
Substance P | 31 | 2007 | 335 | 1.210 |
Why?
|
Cerebral Arteries | 31 | 2007 | 494 | 1.170 |
Why?
|
Brain | 99 | 2023 | 26385 | 1.160 |
Why?
|
Vasodilation | 26 | 2012 | 944 | 1.160 |
Why?
|
Neuroprotective Agents | 21 | 2010 | 941 | 1.130 |
Why?
|
Neurons | 57 | 2017 | 9338 | 1.120 |
Why?
|
Caspases | 16 | 2006 | 928 | 1.070 |
Why?
|
Animals | 372 | 2023 | 168757 | 1.070 |
Why?
|
Serotonin Receptor Agonists | 14 | 2003 | 152 | 0.990 |
Why?
|
Vascular Headaches | 12 | 1994 | 22 | 0.970 |
Why?
|
Proto-Oncogene Proteins c-fos | 13 | 2011 | 575 | 0.960 |
Why?
|
Pressure Ulcer | 7 | 2001 | 155 | 0.950 |
Why?
|
Cerebral Cortex | 31 | 2017 | 5708 | 0.900 |
Why?
|
Mammography | 43 | 2001 | 2476 | 0.900 |
Why?
|
Capsaicin | 28 | 1999 | 231 | 0.890 |
Why?
|
Arginine | 19 | 2008 | 944 | 0.890 |
Why?
|
Sumatriptan | 21 | 2002 | 65 | 0.860 |
Why?
|
Rats | 127 | 2023 | 24260 | 0.850 |
Why?
|
Fibroblast Growth Factor 2 | 8 | 2004 | 599 | 0.840 |
Why?
|
Arterioles | 14 | 2017 | 254 | 0.840 |
Why?
|
Infarction, Middle Cerebral Artery | 19 | 2018 | 475 | 0.820 |
Why?
|
Amino Acid Oxidoreductases | 12 | 1995 | 151 | 0.780 |
Why?
|
Brain Injuries | 14 | 2014 | 2025 | 0.770 |
Why?
|
Cysteine Proteinase Inhibitors | 7 | 2001 | 190 | 0.760 |
Why?
|
Nitroarginine | 12 | 2004 | 66 | 0.750 |
Why?
|
Indoles | 17 | 2008 | 1839 | 0.730 |
Why?
|
Nursing Homes | 8 | 2001 | 1036 | 0.720 |
Why?
|
Mice | 154 | 2022 | 81183 | 0.700 |
Why?
|
Long-Term Care | 7 | 2001 | 607 | 0.690 |
Why?
|
Blood Vessels | 10 | 2010 | 1125 | 0.670 |
Why?
|
Enzyme Inhibitors | 21 | 2018 | 3798 | 0.670 |
Why?
|
Genes, fos | 9 | 2007 | 183 | 0.670 |
Why?
|
Apoptosis | 21 | 2005 | 9727 | 0.660 |
Why?
|
Neurology | 2 | 2018 | 763 | 0.630 |
Why?
|
Endothelium, Vascular | 21 | 2012 | 4456 | 0.620 |
Why?
|
Mice, Knockout | 56 | 2019 | 14557 | 0.620 |
Why?
|
Microcirculation | 7 | 2010 | 1286 | 0.610 |
Why?
|
Risk Adjustment | 5 | 2001 | 594 | 0.600 |
Why?
|
N-Methylaspartate | 5 | 2005 | 231 | 0.600 |
Why?
|
Nitric Oxide Synthase Type III | 19 | 2018 | 689 | 0.600 |
Why?
|
Poly(ADP-ribose) Polymerases | 5 | 2003 | 440 | 0.590 |
Why?
|
Mice, Inbred Strains | 19 | 2005 | 1827 | 0.590 |
Why?
|
Migraine without Aura | 4 | 2022 | 83 | 0.580 |
Why?
|
Disease Models, Animal | 50 | 2020 | 18029 | 0.580 |
Why?
|
Rats, Sprague-Dawley | 50 | 2020 | 8301 | 0.570 |
Why?
|
Trigeminal Nuclei | 8 | 1999 | 41 | 0.570 |
Why?
|
Embolism | 2 | 2010 | 408 | 0.560 |
Why?
|
Cluster Headache | 4 | 2010 | 54 | 0.560 |
Why?
|
Circle of Willis | 6 | 2007 | 68 | 0.560 |
Why?
|
Coronary Artery Bypass | 9 | 1999 | 2289 | 0.560 |
Why?
|
Mice, Inbred C57BL | 62 | 2019 | 21827 | 0.560 |
Why?
|
Clinical Medicine | 1 | 2017 | 147 | 0.550 |
Why?
|
Acetylcholine | 12 | 2006 | 621 | 0.540 |
Why?
|
Guinea Pigs | 27 | 1999 | 1386 | 0.540 |
Why?
|
Receptors, Notch | 4 | 2014 | 739 | 0.530 |
Why?
|
Cysteine Endopeptidases | 5 | 1998 | 563 | 0.530 |
Why?
|
Inflammation | 16 | 2021 | 10638 | 0.520 |
Why?
|
Nociceptors | 9 | 2012 | 432 | 0.520 |
Why?
|
Ischemic Preconditioning | 4 | 2011 | 92 | 0.510 |
Why?
|
Vibrissae | 7 | 2007 | 125 | 0.490 |
Why?
|
Sulfonamides | 14 | 1997 | 1938 | 0.490 |
Why?
|
Cell Death | 14 | 2012 | 1706 | 0.480 |
Why?
|
Nitric Oxide Synthase Type II | 15 | 2007 | 534 | 0.480 |
Why?
|
Blood Proteins | 13 | 2001 | 1124 | 0.470 |
Why?
|
Simvastatin | 5 | 2008 | 360 | 0.470 |
Why?
|
Peptide Hydrolases | 3 | 2007 | 634 | 0.470 |
Why?
|
Valproic Acid | 4 | 1997 | 445 | 0.460 |
Why?
|
Cats | 34 | 1998 | 998 | 0.450 |
Why?
|
Humans | 287 | 2023 | 744343 | 0.450 |
Why?
|
Male | 241 | 2023 | 350118 | 0.450 |
Why?
|
History, 21st Century | 5 | 2022 | 1534 | 0.450 |
Why?
|
Faculty, Medical | 8 | 2001 | 1181 | 0.440 |
Why?
|
Laser-Doppler Flowmetry | 16 | 2008 | 242 | 0.440 |
Why?
|
Trigeminal Caudal Nucleus | 4 | 2011 | 18 | 0.440 |
Why?
|
Breast Neoplasms | 52 | 2001 | 20822 | 0.430 |
Why?
|
Neurotransmitter Agents | 9 | 2007 | 647 | 0.420 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2008 | 3255 | 0.420 |
Why?
|
Corpus Striatum | 9 | 2011 | 1221 | 0.420 |
Why?
|
Serotonin | 16 | 1998 | 1017 | 0.420 |
Why?
|
GABA Agents | 3 | 1996 | 42 | 0.410 |
Why?
|
Neurons, Afferent | 13 | 1997 | 506 | 0.410 |
Why?
|
Hospitals, Veterans | 7 | 1998 | 404 | 0.410 |
Why?
|
Up-Regulation | 12 | 2018 | 4217 | 0.410 |
Why?
|
Skull | 7 | 2023 | 813 | 0.410 |
Why?
|
Cardiovascular System | 2 | 2019 | 832 | 0.410 |
Why?
|
Tissue Plasminogen Activator | 5 | 2007 | 1261 | 0.410 |
Why?
|
Peroxidase | 4 | 2018 | 611 | 0.400 |
Why?
|
Dihydroergotamine | 6 | 1996 | 20 | 0.400 |
Why?
|
Medicare | 18 | 2001 | 6566 | 0.400 |
Why?
|
Autoradiography | 11 | 2004 | 745 | 0.400 |
Why?
|
United States Department of Veterans Affairs | 7 | 2001 | 875 | 0.400 |
Why?
|
Electric Stimulation | 27 | 2006 | 1767 | 0.400 |
Why?
|
History, 20th Century | 5 | 2022 | 2740 | 0.390 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 4 | 1996 | 105 | 0.390 |
Why?
|
Aftercare | 4 | 2000 | 866 | 0.390 |
Why?
|
Leukoencephalopathies | 1 | 2014 | 238 | 0.390 |
Why?
|
Regional Blood Flow | 17 | 2018 | 1525 | 0.380 |
Why?
|
Matrix Metalloproteinase 9 | 6 | 2016 | 638 | 0.380 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2009 | 333 | 0.380 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2011 | 76 | 0.380 |
Why?
|
Mass Screening | 25 | 2001 | 5255 | 0.370 |
Why?
|
Trigeminal Autonomic Cephalalgias | 1 | 2010 | 8 | 0.370 |
Why?
|
Enzyme Activation | 15 | 2009 | 3701 | 0.360 |
Why?
|
HMGB1 Protein | 2 | 2010 | 133 | 0.360 |
Why?
|
Health Services Research | 15 | 2001 | 1836 | 0.360 |
Why?
|
Estrogens | 6 | 2023 | 1566 | 0.360 |
Why?
|
Vasoconstrictor Agents | 9 | 2008 | 642 | 0.350 |
Why?
|
Geriatric Assessment | 5 | 2001 | 1372 | 0.350 |
Why?
|
Neuropeptides | 8 | 2009 | 942 | 0.350 |
Why?
|
Rats, Inbred Strains | 23 | 1992 | 2186 | 0.350 |
Why?
|
Sensory Receptor Cells | 2 | 2012 | 492 | 0.340 |
Why?
|
Corpus Callosum | 1 | 2014 | 737 | 0.340 |
Why?
|
Oxygen | 14 | 2010 | 4189 | 0.330 |
Why?
|
Outpatient Clinics, Hospital | 4 | 1998 | 392 | 0.330 |
Why?
|
Hyperemia | 8 | 2008 | 225 | 0.330 |
Why?
|
Neurogenic Inflammation | 2 | 2006 | 33 | 0.320 |
Why?
|
Gene Expression | 13 | 2002 | 7799 | 0.320 |
Why?
|
Muscle, Smooth, Vascular | 13 | 2008 | 1504 | 0.320 |
Why?
|
Reperfusion | 13 | 2010 | 284 | 0.320 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 9 | 2005 | 895 | 0.310 |
Why?
|
Meningitis, Bacterial | 2 | 2022 | 218 | 0.300 |
Why?
|
Pyrrolidines | 5 | 1997 | 342 | 0.300 |
Why?
|
Hedgehog Proteins | 2 | 2009 | 783 | 0.300 |
Why?
|
Minority Groups | 3 | 2000 | 1223 | 0.300 |
Why?
|
Patient Dropouts | 2 | 2000 | 421 | 0.300 |
Why?
|
Excitatory Amino Acid Antagonists | 6 | 2005 | 449 | 0.290 |
Why?
|
Hypercapnia | 9 | 2007 | 260 | 0.290 |
Why?
|
Brain Stem | 8 | 2017 | 846 | 0.290 |
Why?
|
Hippocampus | 12 | 2011 | 3675 | 0.290 |
Why?
|
Hyperoxia | 2 | 2008 | 262 | 0.290 |
Why?
|
Capillary Permeability | 9 | 1996 | 798 | 0.290 |
Why?
|
Hospital Mortality | 9 | 2000 | 5317 | 0.290 |
Why?
|
Foramen Ovale, Patent | 1 | 2010 | 223 | 0.290 |
Why?
|
Memory Disorders | 1 | 2014 | 1184 | 0.290 |
Why?
|
Central Nervous System | 4 | 2023 | 1357 | 0.290 |
Why?
|
Evoked Potentials | 2 | 2012 | 1056 | 0.290 |
Why?
|
Meningitis | 2 | 2001 | 216 | 0.280 |
Why?
|
Cyclic GMP | 3 | 1998 | 409 | 0.280 |
Why?
|
Severity of Illness Index | 19 | 2005 | 15540 | 0.280 |
Why?
|
Bone Marrow | 6 | 2023 | 2948 | 0.280 |
Why?
|
Ergot Alkaloids | 3 | 1992 | 12 | 0.280 |
Why?
|
Flavoproteins | 2 | 2004 | 43 | 0.280 |
Why?
|
Hospital Costs | 5 | 1999 | 985 | 0.280 |
Why?
|
Caspase 3 | 10 | 2008 | 758 | 0.280 |
Why?
|
Career Mobility | 2 | 1998 | 262 | 0.270 |
Why?
|
Job Satisfaction | 4 | 2000 | 535 | 0.270 |
Why?
|
Patient Discharge | 8 | 2000 | 3313 | 0.270 |
Why?
|
United States | 57 | 2019 | 69872 | 0.270 |
Why?
|
Data Collection | 6 | 2001 | 3341 | 0.270 |
Why?
|
Calcium Channels, P-Type | 2 | 2008 | 9 | 0.270 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 2 | 2021 | 29 | 0.270 |
Why?
|
Epilepsy | 2 | 2022 | 3310 | 0.270 |
Why?
|
Nerve Tissue Proteins | 11 | 2017 | 4462 | 0.270 |
Why?
|
Blood-Brain Barrier | 7 | 2019 | 1017 | 0.270 |
Why?
|
Amino Acid Chloromethyl Ketones | 4 | 2001 | 68 | 0.270 |
Why?
|
Female | 165 | 2023 | 380194 | 0.260 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 590 | 0.260 |
Why?
|
Quality Assurance, Health Care | 4 | 2001 | 2212 | 0.260 |
Why?
|
Stem Cells | 8 | 2012 | 3567 | 0.260 |
Why?
|
Astrocytes | 6 | 2010 | 1270 | 0.260 |
Why?
|
Vasoconstriction | 10 | 2008 | 597 | 0.260 |
Why?
|
Dizocilpine Maleate | 4 | 1998 | 176 | 0.260 |
Why?
|
Neurodegenerative Diseases | 3 | 2009 | 1061 | 0.250 |
Why?
|
Medical Audit | 5 | 2000 | 467 | 0.250 |
Why?
|
Databases, Factual | 8 | 2001 | 7729 | 0.250 |
Why?
|
Aged | 86 | 2020 | 163280 | 0.250 |
Why?
|
Intracranial Embolism | 3 | 2017 | 202 | 0.250 |
Why?
|
Nerve Growth Factors | 5 | 2009 | 574 | 0.250 |
Why?
|
Dentate Gyrus | 3 | 2008 | 160 | 0.250 |
Why?
|
RNA, Messenger | 22 | 2008 | 13033 | 0.240 |
Why?
|
Research | 8 | 2008 | 1999 | 0.240 |
Why?
|
Synaptic Transmission | 6 | 2012 | 1178 | 0.240 |
Why?
|
Encephalitis | 1 | 2007 | 423 | 0.240 |
Why?
|
Activities of Daily Living | 11 | 2000 | 2418 | 0.240 |
Why?
|
Receptors, GABA-A | 3 | 2023 | 627 | 0.230 |
Why?
|
Neuritis | 2 | 1995 | 36 | 0.230 |
Why?
|
NF-kappa B | 2 | 2003 | 2499 | 0.230 |
Why?
|
Epidermal Growth Factor | 2 | 2003 | 708 | 0.230 |
Why?
|
Nerve Fibers | 11 | 1993 | 687 | 0.230 |
Why?
|
Lovastatin | 2 | 2001 | 120 | 0.230 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1375 | 0.230 |
Why?
|
Cells, Cultured | 27 | 2011 | 19229 | 0.230 |
Why?
|
Glucose | 6 | 2004 | 4397 | 0.230 |
Why?
|
Nitrates | 3 | 1999 | 265 | 0.230 |
Why?
|
Rheology | 1 | 2004 | 345 | 0.230 |
Why?
|
Hospital Charges | 3 | 2000 | 362 | 0.220 |
Why?
|
Ambulatory Care | 6 | 2001 | 2708 | 0.220 |
Why?
|
Blood Volume | 10 | 2006 | 565 | 0.220 |
Why?
|
Pneumonia | 3 | 2000 | 2133 | 0.220 |
Why?
|
Axons | 11 | 1997 | 1684 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 29 | 2020 | 35421 | 0.220 |
Why?
|
Immunohistochemistry | 29 | 2011 | 11366 | 0.220 |
Why?
|
Pain | 12 | 2002 | 4986 | 0.220 |
Why?
|
Gelsolin | 3 | 2000 | 190 | 0.220 |
Why?
|
Neural Pathways | 10 | 2019 | 2972 | 0.210 |
Why?
|
Spinal Cord Ischemia | 2 | 2000 | 93 | 0.210 |
Why?
|
Carrier Proteins | 4 | 2009 | 5021 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 19 | 2010 | 10943 | 0.210 |
Why?
|
Blood Pressure | 23 | 2010 | 8554 | 0.210 |
Why?
|
Serum Albumin, Bovine | 4 | 1996 | 324 | 0.210 |
Why?
|
Neurotrophin 3 | 1 | 2002 | 59 | 0.210 |
Why?
|
Vision Disorders | 2 | 2001 | 1058 | 0.210 |
Why?
|
Nerve Degeneration | 3 | 2003 | 748 | 0.210 |
Why?
|
Venules | 2 | 1992 | 165 | 0.200 |
Why?
|
Brain Edema | 3 | 1997 | 617 | 0.200 |
Why?
|
Hospitalization | 10 | 2001 | 10262 | 0.200 |
Why?
|
Signal Transduction | 14 | 2012 | 23403 | 0.200 |
Why?
|
Time Factors | 40 | 2017 | 40075 | 0.200 |
Why?
|
Physical Stimulation | 7 | 2007 | 525 | 0.200 |
Why?
|
Neuroeffector Junction | 2 | 1991 | 2 | 0.200 |
Why?
|
Parvalbumins | 1 | 2003 | 250 | 0.200 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2016 | 604 | 0.200 |
Why?
|
Microinjections | 5 | 2010 | 327 | 0.200 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 225 | 0.200 |
Why?
|
Patient Admission | 8 | 2000 | 1380 | 0.200 |
Why?
|
Specialization | 5 | 2000 | 777 | 0.200 |
Why?
|
Oligopeptides | 4 | 2001 | 1189 | 0.190 |
Why?
|
Isoenzymes | 4 | 2002 | 1726 | 0.190 |
Why?
|
Brain Chemistry | 6 | 2005 | 981 | 0.190 |
Why?
|
Massachusetts | 16 | 2001 | 8663 | 0.190 |
Why?
|
Mutation | 17 | 2011 | 29786 | 0.190 |
Why?
|
Models, Statistical | 7 | 2001 | 5102 | 0.190 |
Why?
|
Cerebellar Ataxia | 3 | 2018 | 145 | 0.190 |
Why?
|
Mice, Transgenic | 17 | 2019 | 9734 | 0.190 |
Why?
|
Analysis of Variance | 14 | 2011 | 6365 | 0.190 |
Why?
|
Patients | 3 | 1997 | 900 | 0.190 |
Why?
|
Carbon Dioxide | 8 | 1999 | 1150 | 0.180 |
Why?
|
Logistic Models | 17 | 2001 | 13408 | 0.180 |
Why?
|
Somatosensory Cortex | 5 | 2015 | 528 | 0.180 |
Why?
|
Arteries | 9 | 2008 | 1119 | 0.180 |
Why?
|
Mice, Mutant Strains | 9 | 2009 | 1866 | 0.180 |
Why?
|
Hospitals | 5 | 1999 | 3952 | 0.180 |
Why?
|
Nursing Assessment | 1 | 2000 | 107 | 0.180 |
Why?
|
Cholecystectomy | 4 | 1995 | 395 | 0.180 |
Why?
|
Patient Participation | 5 | 1999 | 1457 | 0.180 |
Why?
|
Oxygen Consumption | 5 | 2008 | 1869 | 0.180 |
Why?
|
Renal Dialysis | 2 | 1999 | 1786 | 0.170 |
Why?
|
Indazoles | 3 | 1998 | 289 | 0.170 |
Why?
|
Hypertension | 11 | 2008 | 8480 | 0.170 |
Why?
|
Health Resources | 4 | 2001 | 911 | 0.170 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2004 | 87 | 0.170 |
Why?
|
Mast Cells | 5 | 2001 | 1544 | 0.170 |
Why?
|
Pregnanolone | 2 | 1996 | 62 | 0.170 |
Why?
|
DNA Fragmentation | 6 | 2001 | 242 | 0.170 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 3 | 2006 | 92 | 0.170 |
Why?
|
rho-Associated Kinases | 3 | 2018 | 279 | 0.170 |
Why?
|
Occipital Lobe | 2 | 2020 | 379 | 0.170 |
Why?
|
Caspase 1 | 6 | 2000 | 224 | 0.170 |
Why?
|
Middle Aged | 77 | 2020 | 213383 | 0.170 |
Why?
|
Receptors, Glutamate | 4 | 2003 | 232 | 0.170 |
Why?
|
Peripheral Nervous System | 1 | 2000 | 150 | 0.160 |
Why?
|
Vasodilator Agents | 6 | 2008 | 977 | 0.160 |
Why?
|
Pyrroles | 5 | 2005 | 1146 | 0.160 |
Why?
|
Injections, Intraventricular | 6 | 2006 | 230 | 0.160 |
Why?
|
CADASIL | 2 | 2011 | 84 | 0.160 |
Why?
|
Analgesics | 2 | 2003 | 1040 | 0.160 |
Why?
|
Neurotoxins | 3 | 1998 | 237 | 0.160 |
Why?
|
Excitatory Amino Acid Agonists | 2 | 2005 | 146 | 0.160 |
Why?
|
Lymphopoiesis | 1 | 2019 | 135 | 0.160 |
Why?
|
Receptors, Glucocorticoid | 2 | 2019 | 302 | 0.160 |
Why?
|
Hip Fractures | 3 | 2000 | 955 | 0.160 |
Why?
|
Functional Laterality | 6 | 2010 | 2290 | 0.160 |
Why?
|
Intensive Care Units | 5 | 2000 | 3679 | 0.160 |
Why?
|
Interneurons | 1 | 2003 | 577 | 0.160 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1997 | 40 | 0.160 |
Why?
|
Treatment Refusal | 2 | 1999 | 421 | 0.160 |
Why?
|
Brain Damage, Chronic | 2 | 2004 | 265 | 0.160 |
Why?
|
Salaries and Fringe Benefits | 2 | 2000 | 264 | 0.160 |
Why?
|
Evaluation Studies as Topic | 9 | 2001 | 1681 | 0.160 |
Why?
|
Altitude Sickness | 1 | 1999 | 92 | 0.160 |
Why?
|
Alcoholism | 2 | 2000 | 1906 | 0.160 |
Why?
|
Tissue Distribution | 8 | 2004 | 2327 | 0.160 |
Why?
|
NG-Nitroarginine Methyl Ester | 7 | 2006 | 255 | 0.150 |
Why?
|
Nervous System Physiological Phenomena | 2 | 1998 | 117 | 0.150 |
Why?
|
Head Injuries, Penetrating | 1 | 2017 | 28 | 0.150 |
Why?
|
Imidazoles | 5 | 2008 | 1206 | 0.150 |
Why?
|
Practice Guidelines as Topic | 2 | 2008 | 7279 | 0.150 |
Why?
|
Altitude | 1 | 1999 | 161 | 0.150 |
Why?
|
Attitude to Health | 4 | 2001 | 2052 | 0.150 |
Why?
|
Neuronal Plasticity | 4 | 2013 | 1422 | 0.150 |
Why?
|
Virulence Factors, Bordetella | 2 | 1997 | 156 | 0.150 |
Why?
|
Cytochrome c Group | 3 | 2002 | 128 | 0.150 |
Why?
|
Enkephalins | 4 | 1990 | 154 | 0.150 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2017 | 23 | 0.150 |
Why?
|
Pertussis Toxin | 2 | 1997 | 178 | 0.150 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 1999 | 219 | 0.150 |
Why?
|
Utilization Review | 1 | 1999 | 392 | 0.150 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 1999 | 211 | 0.150 |
Why?
|
Health Services | 2 | 2001 | 758 | 0.150 |
Why?
|
Quality of Health Care | 7 | 2001 | 4371 | 0.150 |
Why?
|
Personal Autonomy | 2 | 1990 | 298 | 0.150 |
Why?
|
Medicine | 4 | 2000 | 946 | 0.150 |
Why?
|
Oxazolidinones | 1 | 1997 | 96 | 0.150 |
Why?
|
Potassium | 5 | 2006 | 1336 | 0.150 |
Why?
|
Point Mutation | 3 | 2009 | 1623 | 0.150 |
Why?
|
Adrenal Cortex Hormones | 3 | 2019 | 1855 | 0.150 |
Why?
|
In Situ Nick-End Labeling | 6 | 2007 | 643 | 0.150 |
Why?
|
4-Aminobenzoic Acid | 1 | 2016 | 22 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2017 | 85 | 0.150 |
Why?
|
Poly Adenosine Diphosphate Ribose | 3 | 2003 | 49 | 0.150 |
Why?
|
Afferent Pathways | 8 | 1993 | 302 | 0.150 |
Why?
|
Nurse Practitioners | 1 | 2000 | 270 | 0.140 |
Why?
|
Ganglionectomy | 4 | 1991 | 12 | 0.140 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2010 | 1018 | 0.140 |
Why?
|
Horseradish Peroxidase | 6 | 1992 | 166 | 0.140 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 1998 | 165 | 0.140 |
Why?
|
Tachykinins | 4 | 1990 | 78 | 0.140 |
Why?
|
Dynorphins | 2 | 1987 | 84 | 0.140 |
Why?
|
Receptors, Neuropeptide Y | 1 | 1996 | 44 | 0.140 |
Why?
|
Random Allocation | 6 | 2014 | 2429 | 0.140 |
Why?
|
Primary Health Care | 4 | 2001 | 4558 | 0.140 |
Why?
|
Medical Records | 4 | 1998 | 1413 | 0.140 |
Why?
|
Bromodeoxyuridine | 5 | 2004 | 322 | 0.140 |
Why?
|
Homes for the Aged | 1 | 1999 | 260 | 0.140 |
Why?
|
Nitric Oxide Synthase Type I | 7 | 2007 | 170 | 0.140 |
Why?
|
GABA Modulators | 1 | 1996 | 107 | 0.140 |
Why?
|
Length of Stay | 8 | 1999 | 6309 | 0.140 |
Why?
|
Oxazoles | 1 | 1997 | 189 | 0.140 |
Why?
|
Models, Neurological | 7 | 2009 | 1774 | 0.140 |
Why?
|
Physical Examination | 11 | 2006 | 1237 | 0.140 |
Why?
|
Gene Expression Regulation | 8 | 2009 | 12072 | 0.140 |
Why?
|
Progesterone | 2 | 2023 | 776 | 0.140 |
Why?
|
Erectile Dysfunction | 1 | 2000 | 461 | 0.140 |
Why?
|
Tritium | 6 | 1998 | 745 | 0.140 |
Why?
|
Enzyme Precursors | 3 | 2002 | 176 | 0.140 |
Why?
|
Washington | 4 | 2000 | 313 | 0.140 |
Why?
|
Residential Facilities | 1 | 1996 | 43 | 0.140 |
Why?
|
Neuropeptide Y | 2 | 1996 | 200 | 0.140 |
Why?
|
Caudate Nucleus | 2 | 2002 | 393 | 0.140 |
Why?
|
Quinoxalines | 4 | 2000 | 290 | 0.130 |
Why?
|
Recovery of Function | 4 | 2016 | 2925 | 0.130 |
Why?
|
Genotype | 5 | 2011 | 12951 | 0.130 |
Why?
|
Prostaglandins | 6 | 1984 | 405 | 0.130 |
Why?
|
Catecholamines | 6 | 1975 | 387 | 0.130 |
Why?
|
Cell Proliferation | 3 | 2016 | 10481 | 0.130 |
Why?
|
Bone Marrow Cells | 2 | 2019 | 2513 | 0.130 |
Why?
|
Serotonin Antagonists | 6 | 1999 | 144 | 0.130 |
Why?
|
Myeloid Cells | 2 | 2018 | 810 | 0.130 |
Why?
|
Sleep Deprivation | 2 | 2020 | 832 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 2 | 2010 | 565 | 0.130 |
Why?
|
Administration, Topical | 5 | 1996 | 690 | 0.130 |
Why?
|
Estrogen Replacement Therapy | 3 | 2001 | 1203 | 0.130 |
Why?
|
Basilar Artery | 4 | 2008 | 200 | 0.130 |
Why?
|
Connexins | 1 | 2017 | 357 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 3 | 2000 | 793 | 0.130 |
Why?
|
Data Interpretation, Statistical | 5 | 2006 | 2716 | 0.130 |
Why?
|
Menopause | 2 | 1997 | 1626 | 0.130 |
Why?
|
Stimulation, Chemical | 5 | 2006 | 326 | 0.130 |
Why?
|
Endarterectomy, Carotid | 1 | 2000 | 546 | 0.130 |
Why?
|
Radioimmunoassay | 9 | 1989 | 919 | 0.130 |
Why?
|
Transcription, Genetic | 4 | 2007 | 7722 | 0.130 |
Why?
|
Receptors, GABA | 1 | 1996 | 288 | 0.130 |
Why?
|
Motor Activity | 6 | 2009 | 2714 | 0.120 |
Why?
|
Microglia | 1 | 2003 | 1266 | 0.120 |
Why?
|
Cranial Sinuses | 2 | 1991 | 66 | 0.120 |
Why?
|
Mitochondria | 5 | 2005 | 3520 | 0.120 |
Why?
|
Potassium Chloride | 5 | 2011 | 237 | 0.120 |
Why?
|
Mice, Neurologic Mutants | 3 | 2011 | 126 | 0.120 |
Why?
|
Perfusion | 3 | 2010 | 1360 | 0.120 |
Why?
|
Surgical Procedures, Operative | 3 | 1999 | 1876 | 0.120 |
Why?
|
Phenotype | 8 | 2022 | 16365 | 0.120 |
Why?
|
Survival Analysis | 5 | 2000 | 10252 | 0.120 |
Why?
|
Carotid Stenosis | 2 | 2007 | 854 | 0.120 |
Why?
|
Coronary Disease | 3 | 1999 | 6077 | 0.120 |
Why?
|
Skilled Nursing Facilities | 1 | 1998 | 372 | 0.120 |
Why?
|
Glutamic Acid | 4 | 2007 | 1169 | 0.120 |
Why?
|
Nitroglycerin | 3 | 2002 | 325 | 0.120 |
Why?
|
Vascular Diseases | 2 | 2019 | 1161 | 0.120 |
Why?
|
Aged, 80 and over | 27 | 2008 | 57776 | 0.120 |
Why?
|
Physician-Patient Relations | 8 | 1999 | 3229 | 0.120 |
Why?
|
Myelopoiesis | 1 | 2014 | 133 | 0.120 |
Why?
|
Predictive Value of Tests | 13 | 2001 | 15076 | 0.120 |
Why?
|
Brain Mapping | 7 | 2013 | 6669 | 0.120 |
Why?
|
Biocompatible Materials | 1 | 2002 | 1736 | 0.120 |
Why?
|
Arachnoid | 2 | 1983 | 48 | 0.120 |
Why?
|
Internal Medicine | 6 | 2001 | 1009 | 0.120 |
Why?
|
Cell Division | 7 | 2004 | 4568 | 0.120 |
Why?
|
Health Services for the Aged | 1 | 1996 | 269 | 0.120 |
Why?
|
Huntington Disease | 5 | 2011 | 1124 | 0.120 |
Why?
|
Rats, Wistar | 8 | 2004 | 1901 | 0.110 |
Why?
|
Reperfusion Injury | 4 | 2010 | 1026 | 0.110 |
Why?
|
Caffeine | 1 | 2018 | 699 | 0.110 |
Why?
|
Neuroglia | 3 | 2010 | 927 | 0.110 |
Why?
|
Drug Synergism | 4 | 2008 | 1792 | 0.110 |
Why?
|
Pineal Gland | 3 | 1980 | 166 | 0.110 |
Why?
|
Hospital Administration | 1 | 1997 | 353 | 0.110 |
Why?
|
Fees and Charges | 3 | 1991 | 195 | 0.110 |
Why?
|
Conjunctiva | 3 | 1994 | 494 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2018 | 986 | 0.110 |
Why?
|
Multivariate Analysis | 9 | 2001 | 12245 | 0.110 |
Why?
|
American Heart Association | 1 | 2017 | 1056 | 0.110 |
Why?
|
Fibrinolysis | 2 | 2004 | 322 | 0.110 |
Why?
|
Treatment Outcome | 15 | 2008 | 63114 | 0.110 |
Why?
|
Norepinephrine | 5 | 2014 | 909 | 0.110 |
Why?
|
Iodine Radioisotopes | 6 | 2004 | 1032 | 0.110 |
Why?
|
Awareness | 1 | 1997 | 640 | 0.110 |
Why?
|
Visual Cortex | 1 | 2001 | 1149 | 0.110 |
Why?
|
Nitric Oxide Donors | 2 | 2003 | 121 | 0.110 |
Why?
|
Mentors | 1 | 1998 | 631 | 0.110 |
Why?
|
Boston | 13 | 1999 | 9313 | 0.110 |
Why?
|
Protein Kinase C | 1 | 1997 | 1227 | 0.110 |
Why?
|
Rats, Inbred SHR | 6 | 1998 | 195 | 0.110 |
Why?
|
Vascular Resistance | 4 | 1997 | 936 | 0.110 |
Why?
|
Emigration and Immigration | 1 | 1996 | 404 | 0.110 |
Why?
|
Trans-Activators | 1 | 2002 | 2924 | 0.110 |
Why?
|
Communication Barriers | 1 | 1996 | 398 | 0.110 |
Why?
|
Radiation Oncology | 1 | 1998 | 555 | 0.110 |
Why?
|
Mortality | 4 | 1999 | 2864 | 0.110 |
Why?
|
Sigmoidoscopy | 1 | 1993 | 156 | 0.110 |
Why?
|
Age Factors | 20 | 2001 | 18370 | 0.110 |
Why?
|
Risk | 13 | 2007 | 9687 | 0.110 |
Why?
|
Endothelin-1 | 1 | 2014 | 314 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 2 | 2008 | 712 | 0.110 |
Why?
|
Spinal Cord | 2 | 2000 | 1809 | 0.110 |
Why?
|
Prostatic Hyperplasia | 1 | 1996 | 523 | 0.110 |
Why?
|
Basal Ganglia | 3 | 2004 | 546 | 0.110 |
Why?
|
Free Radicals | 2 | 2003 | 237 | 0.110 |
Why?
|
Sex Factors | 8 | 2000 | 10397 | 0.100 |
Why?
|
Resuscitation Orders | 2 | 1991 | 269 | 0.100 |
Why?
|
Adult | 55 | 2020 | 214055 | 0.100 |
Why?
|
Tetanus | 3 | 1989 | 53 | 0.100 |
Why?
|
Home Care Services | 2 | 2000 | 606 | 0.100 |
Why?
|
Hemodynamics | 11 | 2000 | 4199 | 0.100 |
Why?
|
Social Values | 2 | 1990 | 224 | 0.100 |
Why?
|
Interleukin-1 | 4 | 2001 | 1263 | 0.100 |
Why?
|
Genes, jun | 1 | 1991 | 71 | 0.100 |
Why?
|
Ischemia | 6 | 2011 | 1907 | 0.100 |
Why?
|
Health Expenditures | 3 | 2001 | 2348 | 0.100 |
Why?
|
Prospective Payment System | 2 | 1998 | 133 | 0.100 |
Why?
|
Gene Knock-In Techniques | 2 | 2011 | 418 | 0.100 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2012 | 60 | 0.100 |
Why?
|
Albumins | 2 | 2006 | 569 | 0.100 |
Why?
|
Indomethacin | 2 | 1989 | 332 | 0.100 |
Why?
|
Membrane Proteins | 4 | 2004 | 7880 | 0.100 |
Why?
|
Cattle | 14 | 2006 | 3922 | 0.100 |
Why?
|
Southeastern United States | 2 | 2001 | 95 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2002 | 2916 | 0.100 |
Why?
|
Cell Movement | 3 | 2018 | 5217 | 0.100 |
Why?
|
Sphingosine | 2 | 2004 | 307 | 0.100 |
Why?
|
Pyridines | 6 | 2005 | 2825 | 0.100 |
Why?
|
Hypotension | 4 | 2010 | 884 | 0.100 |
Why?
|
Ganglia | 3 | 1989 | 89 | 0.100 |
Why?
|
Lysophospholipids | 2 | 2004 | 331 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8949 | 0.100 |
Why?
|
Risk Factors | 18 | 2010 | 72290 | 0.100 |
Why?
|
Nerve Regeneration | 2 | 2009 | 788 | 0.100 |
Why?
|
Visual Fields | 1 | 1998 | 1047 | 0.100 |
Why?
|
Biotin | 2 | 1998 | 254 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2002 | 2219 | 0.100 |
Why?
|
Bulimia | 1 | 1993 | 382 | 0.090 |
Why?
|
Raphe Nuclei | 3 | 1997 | 104 | 0.090 |
Why?
|
Chlamydia trachomatis | 1 | 1992 | 246 | 0.090 |
Why?
|
Pennsylvania | 5 | 1999 | 613 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2002 | 2077 | 0.090 |
Why?
|
Inflammation Mediators | 3 | 2005 | 1889 | 0.090 |
Why?
|
Decision Making | 11 | 1999 | 3887 | 0.090 |
Why?
|
Models, Biological | 7 | 2012 | 9583 | 0.090 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2002 | 329 | 0.090 |
Why?
|
Clinical Trials as Topic | 8 | 2009 | 7913 | 0.090 |
Why?
|
Neprilysin | 1 | 1993 | 439 | 0.090 |
Why?
|
Lasers | 3 | 2004 | 952 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2016 | 9648 | 0.090 |
Why?
|
Ganglia, Spinal | 3 | 1997 | 519 | 0.090 |
Why?
|
Bradykinin | 2 | 1990 | 214 | 0.090 |
Why?
|
Oxadiazoles | 3 | 1999 | 93 | 0.090 |
Why?
|
Neurogenesis | 1 | 2016 | 838 | 0.090 |
Why?
|
Synapses | 3 | 2007 | 1728 | 0.090 |
Why?
|
Regression Analysis | 9 | 2001 | 6459 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2010 | 201 | 0.090 |
Why?
|
Neoplasm Staging | 3 | 2000 | 11031 | 0.090 |
Why?
|
Tongue | 2 | 1992 | 406 | 0.090 |
Why?
|
Behavior, Animal | 3 | 2014 | 1881 | 0.090 |
Why?
|
Retrospective Studies | 18 | 2001 | 77449 | 0.090 |
Why?
|
Vaginal Smears | 1 | 1992 | 511 | 0.090 |
Why?
|
Georgia | 2 | 2000 | 186 | 0.090 |
Why?
|
Nervous System Diseases | 6 | 1997 | 1622 | 0.090 |
Why?
|
Methysergide | 1 | 1988 | 28 | 0.090 |
Why?
|
Calcium Channels, Q-Type | 1 | 2008 | 4 | 0.090 |
Why?
|
Toll-Like Receptor 2 | 2 | 2010 | 354 | 0.090 |
Why?
|
Critical Care | 3 | 1991 | 2647 | 0.090 |
Why?
|
Calcium Channels, N-Type | 2 | 2011 | 39 | 0.080 |
Why?
|
Dextroamphetamine | 4 | 1978 | 129 | 0.080 |
Why?
|
Paternalism | 1 | 1989 | 46 | 0.080 |
Why?
|
Ion Pumps | 1 | 2008 | 15 | 0.080 |
Why?
|
Odds Ratio | 6 | 2001 | 9849 | 0.080 |
Why?
|
Haloperidol | 2 | 1989 | 397 | 0.080 |
Why?
|
Dantrolene | 1 | 2008 | 26 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2006 | 2915 | 0.080 |
Why?
|
Nimodipine | 1 | 2008 | 55 | 0.080 |
Why?
|
Interleukin-10 | 2 | 2005 | 1200 | 0.080 |
Why?
|
Neurites | 1 | 2011 | 388 | 0.080 |
Why?
|
Connecticut | 2 | 2000 | 366 | 0.080 |
Why?
|
Myocardial Infarction | 4 | 2012 | 11727 | 0.080 |
Why?
|
Neurosciences | 1 | 2013 | 348 | 0.080 |
Why?
|
Chlamydia Infections | 1 | 1992 | 365 | 0.080 |
Why?
|
Head | 2 | 2023 | 880 | 0.080 |
Why?
|
SRS-A | 3 | 1989 | 156 | 0.080 |
Why?
|
Plasma | 2 | 1991 | 575 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2007 | 1213 | 0.080 |
Why?
|
Reproducibility of Results | 11 | 2004 | 19905 | 0.080 |
Why?
|
Hospitals, Urban | 3 | 1997 | 499 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2011 | 4751 | 0.080 |
Why?
|
Citrulline | 2 | 1999 | 105 | 0.080 |
Why?
|
Aorta | 9 | 2008 | 2061 | 0.080 |
Why?
|
Cyclooxygenase 2 | 2 | 2002 | 611 | 0.080 |
Why?
|
Monocytes | 3 | 2014 | 2596 | 0.080 |
Why?
|
rac GTP-Binding Proteins | 1 | 2009 | 164 | 0.080 |
Why?
|
Culture Media | 8 | 2004 | 908 | 0.080 |
Why?
|
Hydroxyl Radical | 2 | 1999 | 78 | 0.080 |
Why?
|
Platelet Activation | 1 | 1992 | 673 | 0.080 |
Why?
|
Lung Diseases, Obstructive | 2 | 2000 | 316 | 0.080 |
Why?
|
Ganglia, Sympathetic | 2 | 1991 | 62 | 0.080 |
Why?
|
Attitude of Health Personnel | 4 | 2001 | 3843 | 0.080 |
Why?
|
Minnesota | 4 | 1999 | 344 | 0.080 |
Why?
|
Hypothermia | 2 | 2003 | 189 | 0.080 |
Why?
|
Postoperative Complications | 6 | 1999 | 15295 | 0.080 |
Why?
|
Robotics | 2 | 2013 | 899 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 323 | 0.080 |
Why?
|
Muscle Relaxants, Central | 1 | 2008 | 86 | 0.080 |
Why?
|
Dopamine | 8 | 2000 | 1591 | 0.080 |
Why?
|
Dipyridamole | 1 | 2008 | 145 | 0.080 |
Why?
|
Protein Biosynthesis | 6 | 1989 | 2126 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 4 | 2001 | 3022 | 0.080 |
Why?
|
Ganglia, Parasympathetic | 2 | 1993 | 19 | 0.080 |
Why?
|
Coumarins | 2 | 1998 | 119 | 0.080 |
Why?
|
Leukotrienes | 2 | 1989 | 255 | 0.080 |
Why?
|
Insurance Claim Reporting | 2 | 2000 | 163 | 0.080 |
Why?
|
Cerebral Hemorrhage | 4 | 2005 | 2647 | 0.080 |
Why?
|
Reference Values | 6 | 2002 | 4982 | 0.080 |
Why?
|
Propidium | 1 | 2007 | 41 | 0.080 |
Why?
|
Prions | 1 | 2009 | 180 | 0.080 |
Why?
|
Texas | 4 | 1999 | 392 | 0.080 |
Why?
|
Life Support Care | 1 | 1989 | 228 | 0.080 |
Why?
|
Probability | 5 | 1998 | 2505 | 0.080 |
Why?
|
Physicians, Women | 4 | 1999 | 486 | 0.080 |
Why?
|
Costs and Cost Analysis | 4 | 1995 | 1681 | 0.080 |
Why?
|
Family Practice | 3 | 2001 | 516 | 0.080 |
Why?
|
Paresis | 1 | 2008 | 179 | 0.080 |
Why?
|
Anesthesia | 2 | 1997 | 1561 | 0.080 |
Why?
|
Electroencephalography | 4 | 2017 | 6150 | 0.080 |
Why?
|
Cavernous Sinus | 1 | 1988 | 125 | 0.080 |
Why?
|
Family | 1 | 1998 | 3147 | 0.080 |
Why?
|
Tissue Culture Techniques | 5 | 2008 | 290 | 0.070 |
Why?
|
Hyperalgesia | 1 | 2011 | 502 | 0.070 |
Why?
|
Physicians | 3 | 1997 | 4567 | 0.070 |
Why?
|
Contraceptives, Oral | 1 | 1990 | 564 | 0.070 |
Why?
|
Sodium Hypochlorite | 1 | 1987 | 30 | 0.070 |
Why?
|
Peptide Fragments | 4 | 2005 | 5097 | 0.070 |
Why?
|
Polyribosomes | 4 | 1978 | 110 | 0.070 |
Why?
|
Bicuculline | 3 | 1996 | 99 | 0.070 |
Why?
|
Contrast Media | 7 | 2007 | 5300 | 0.070 |
Why?
|
Macrophages | 3 | 2012 | 5655 | 0.070 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2000 | 473 | 0.070 |
Why?
|
Withholding Treatment | 1 | 1991 | 599 | 0.070 |
Why?
|
Urinary Incontinence | 2 | 2001 | 496 | 0.070 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2007 | 859 | 0.070 |
Why?
|
gamma-Aminobutyric Acid | 4 | 2001 | 1121 | 0.070 |
Why?
|
Angiopoietin-1 | 1 | 2007 | 114 | 0.070 |
Why?
|
Gerbillinae | 8 | 2001 | 89 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 1990 | 547 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.070 |
Why?
|
Glossopharyngeal Nerve | 1 | 1986 | 18 | 0.070 |
Why?
|
Blood Cells | 1 | 1988 | 309 | 0.070 |
Why?
|
Femoral Neck Fractures | 2 | 1999 | 138 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4665 | 0.070 |
Why?
|
Endorphins | 1 | 1986 | 75 | 0.070 |
Why?
|
Receptor, Adenosine A2A | 2 | 2004 | 124 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2010 | 930 | 0.070 |
Why?
|
Stem Cell Transplantation | 3 | 2004 | 1620 | 0.070 |
Why?
|
Blotting, Western | 7 | 2005 | 5179 | 0.070 |
Why?
|
Glycoproteins | 2 | 2005 | 2263 | 0.070 |
Why?
|
Sincalide | 1 | 1985 | 16 | 0.070 |
Why?
|
NAD | 2 | 2002 | 593 | 0.070 |
Why?
|
Oxyhemoglobins | 2 | 2008 | 216 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 907 | 0.070 |
Why?
|
Pravastatin | 1 | 2008 | 395 | 0.070 |
Why?
|
Nuclear Envelope | 1 | 2007 | 172 | 0.070 |
Why?
|
Culture Media, Conditioned | 1 | 2007 | 537 | 0.070 |
Why?
|
Spectrum Analysis | 1 | 2008 | 454 | 0.070 |
Why?
|
Socioeconomic Factors | 8 | 2001 | 7785 | 0.070 |
Why?
|
Comorbidity | 6 | 1998 | 10388 | 0.070 |
Why?
|
Homeostasis | 6 | 2009 | 3340 | 0.070 |
Why?
|
Hydroxydopamines | 3 | 1987 | 59 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4328 | 0.070 |
Why?
|
Apoptosis Inducing Factor | 2 | 2004 | 55 | 0.070 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2005 | 16 | 0.070 |
Why?
|
Angiopoietin-2 | 1 | 2007 | 173 | 0.070 |
Why?
|
Arteritis | 2 | 1985 | 159 | 0.070 |
Why?
|
Dystonia | 1 | 1989 | 363 | 0.070 |
Why?
|
Menstruation | 1 | 2007 | 302 | 0.070 |
Why?
|
Receptors, Neurotransmitter | 1 | 1986 | 178 | 0.070 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2006 | 202 | 0.070 |
Why?
|
Gene Deletion | 4 | 2018 | 2751 | 0.070 |
Why?
|
Epoprostenol | 6 | 1986 | 254 | 0.070 |
Why?
|
Cyclophilins | 1 | 2005 | 46 | 0.070 |
Why?
|
DNA Primers | 5 | 2011 | 2892 | 0.070 |
Why?
|
Drug Interactions | 3 | 2006 | 1460 | 0.070 |
Why?
|
GABA Antagonists | 2 | 1996 | 128 | 0.070 |
Why?
|
Research Design | 6 | 1998 | 5987 | 0.070 |
Why?
|
Cardiopulmonary Bypass | 1 | 2011 | 1066 | 0.070 |
Why?
|
Cost-Benefit Analysis | 5 | 2000 | 5391 | 0.070 |
Why?
|
Extracellular Space | 1 | 2007 | 594 | 0.070 |
Why?
|
Dogs | 6 | 2000 | 3912 | 0.070 |
Why?
|
Middle Cerebral Artery | 2 | 2007 | 264 | 0.070 |
Why?
|
Facial Nerve | 2 | 1997 | 271 | 0.070 |
Why?
|
Platelet Aggregation | 2 | 2008 | 798 | 0.070 |
Why?
|
Peptide Biosynthesis | 1 | 1985 | 55 | 0.060 |
Why?
|
Cell Nucleus | 3 | 2004 | 2969 | 0.060 |
Why?
|
Platelet-Derived Growth Factor | 4 | 1986 | 625 | 0.060 |
Why?
|
Nuclear Proteins | 4 | 2016 | 5853 | 0.060 |
Why?
|
Calcium Channels | 3 | 2009 | 622 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2010 | 1423 | 0.060 |
Why?
|
Baclofen | 2 | 1995 | 129 | 0.060 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2005 | 143 | 0.060 |
Why?
|
Binding Sites | 4 | 1998 | 6114 | 0.060 |
Why?
|
Cerebellar Cortex | 1 | 2005 | 107 | 0.060 |
Why?
|
Patient Compliance | 2 | 1993 | 2684 | 0.060 |
Why?
|
Phosphatidylinositols | 1 | 1986 | 291 | 0.060 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 1985 | 36 | 0.060 |
Why?
|
Linear Models | 4 | 1999 | 5952 | 0.060 |
Why?
|
Disease Susceptibility | 4 | 2011 | 1782 | 0.060 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2008 | 356 | 0.060 |
Why?
|
Immunoenzyme Techniques | 5 | 1991 | 1799 | 0.060 |
Why?
|
Isoindoles | 2 | 1995 | 41 | 0.060 |
Why?
|
Thermography | 3 | 1984 | 67 | 0.060 |
Why?
|
Resuscitation | 1 | 1989 | 658 | 0.060 |
Why?
|
Cocaine | 2 | 2001 | 1007 | 0.060 |
Why?
|
Vasomotor System | 2 | 2003 | 209 | 0.060 |
Why?
|
Axonal Transport | 4 | 1992 | 177 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 4 | 2001 | 957 | 0.060 |
Why?
|
Sodium Chloride | 3 | 1994 | 625 | 0.060 |
Why?
|
Melatonin | 4 | 1978 | 721 | 0.060 |
Why?
|
Intracellular Membranes | 1 | 2005 | 390 | 0.060 |
Why?
|
Cytoskeleton | 2 | 2000 | 1185 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2003 | 424 | 0.060 |
Why?
|
Blood Flow Velocity | 4 | 2001 | 1423 | 0.060 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2007 | 367 | 0.060 |
Why?
|
Growth Substances | 4 | 1981 | 784 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6234 | 0.060 |
Why?
|
Carotid Arteries | 6 | 1991 | 952 | 0.060 |
Why?
|
Tyrosine | 2 | 1999 | 1461 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2007 | 572 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.060 |
Why?
|
Thyroid Hormones | 1 | 2006 | 390 | 0.060 |
Why?
|
Prosencephalon | 2 | 1997 | 303 | 0.060 |
Why?
|
Peptones | 2 | 1973 | 5 | 0.060 |
Why?
|
Differential Threshold | 2 | 2000 | 80 | 0.060 |
Why?
|
Heart Rate | 6 | 1999 | 4091 | 0.060 |
Why?
|
Clinical Competence | 2 | 1998 | 4687 | 0.060 |
Why?
|
Base Sequence | 5 | 2004 | 12797 | 0.060 |
Why?
|
Piperazines | 3 | 1999 | 2488 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2282 | 0.060 |
Why?
|
Fibroblasts | 3 | 2007 | 4161 | 0.060 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2003 | 31 | 0.060 |
Why?
|
Glutamates | 2 | 2023 | 398 | 0.060 |
Why?
|
Immunoblotting | 2 | 2011 | 1682 | 0.060 |
Why?
|
Protein Precursors | 4 | 2000 | 1154 | 0.060 |
Why?
|
Lipopolysaccharides | 3 | 2003 | 2216 | 0.060 |
Why?
|
Vasoactive Intestinal Peptide | 6 | 1993 | 179 | 0.060 |
Why?
|
Schools, Medical | 3 | 1998 | 880 | 0.060 |
Why?
|
Sensation | 1 | 1985 | 336 | 0.060 |
Why?
|
Referral and Consultation | 2 | 1987 | 3528 | 0.060 |
Why?
|
Blood Glucose | 1 | 1998 | 6256 | 0.060 |
Why?
|
Heptanoic Acids | 1 | 2005 | 343 | 0.060 |
Why?
|
Myocardial Ischemia | 1 | 2014 | 2148 | 0.060 |
Why?
|
Receptors, Adrenergic | 2 | 1980 | 155 | 0.060 |
Why?
|
Carbon | 2 | 1997 | 687 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2503 | 0.060 |
Why?
|
Mutation, Missense | 2 | 2011 | 2564 | 0.060 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 2002 | 43 | 0.050 |
Why?
|
Gene Transfer, Horizontal | 1 | 2003 | 145 | 0.050 |
Why?
|
Cytochalasin D | 2 | 2000 | 92 | 0.050 |
Why?
|
Health Promotion | 1 | 1995 | 2205 | 0.050 |
Why?
|
Chloralose | 2 | 2008 | 14 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 1989 | 1572 | 0.050 |
Why?
|
Whole-Body Irradiation | 1 | 2003 | 449 | 0.050 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2002 | 23 | 0.050 |
Why?
|
Urethane | 2 | 2008 | 40 | 0.050 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2002 | 27 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 640 | 0.050 |
Why?
|
Cardiac Output | 2 | 1995 | 854 | 0.050 |
Why?
|
Cell Differentiation | 6 | 2009 | 11483 | 0.050 |
Why?
|
Benchmarking | 2 | 1999 | 1042 | 0.050 |
Why?
|
Injections, Intravenous | 4 | 2004 | 1420 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 1989 | 1265 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 1998 | 5751 | 0.050 |
Why?
|
Medical Record Linkage | 2 | 2001 | 284 | 0.050 |
Why?
|
Excipients | 1 | 2002 | 96 | 0.050 |
Why?
|
Adenosine Triphosphate | 3 | 2011 | 2025 | 0.050 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2002 | 48 | 0.050 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2002 | 225 | 0.050 |
Why?
|
Chondroitin Sulfates | 1 | 2002 | 187 | 0.050 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2004 | 370 | 0.050 |
Why?
|
Cell Survival | 3 | 2002 | 5882 | 0.050 |
Why?
|
Electrophysiology | 2 | 2008 | 1308 | 0.050 |
Why?
|
Receptor, trkC | 1 | 2002 | 68 | 0.050 |
Why?
|
Cell Count | 6 | 2004 | 1856 | 0.050 |
Why?
|
Prostaglandin Antagonists | 1 | 1981 | 30 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17446 | 0.050 |
Why?
|
Anesthetics | 1 | 2008 | 539 | 0.050 |
Why?
|
Ultrasonic Therapy | 1 | 2004 | 235 | 0.050 |
Why?
|
Publishing | 3 | 1998 | 833 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2007 | 3760 | 0.050 |
Why?
|
Outliers, DRG | 1 | 2001 | 5 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12959 | 0.050 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2004 | 243 | 0.050 |
Why?
|
Oxidants | 2 | 1999 | 164 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.050 |
Why?
|
Research Support as Topic | 3 | 1998 | 705 | 0.050 |
Why?
|
Stereoisomerism | 2 | 1992 | 624 | 0.050 |
Why?
|
Hemiplegia | 1 | 2022 | 135 | 0.050 |
Why?
|
Adiponectin | 1 | 2007 | 1100 | 0.050 |
Why?
|
Particle Size | 2 | 2004 | 1642 | 0.050 |
Why?
|
Lectins | 1 | 1984 | 513 | 0.050 |
Why?
|
Antibodies | 3 | 2007 | 2460 | 0.050 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2001 | 58 | 0.050 |
Why?
|
Crosses, Genetic | 2 | 2003 | 791 | 0.050 |
Why?
|
Isomerism | 2 | 2005 | 201 | 0.050 |
Why?
|
Cyclins | 1 | 2004 | 603 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2005 | 4386 | 0.050 |
Why?
|
Butadienes | 1 | 2001 | 110 | 0.050 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 216 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2002 | 308 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2002 | 402 | 0.050 |
Why?
|
Species Specificity | 4 | 2000 | 2478 | 0.050 |
Why?
|
Receptors, Serotonin, 5-HT1 | 2 | 1997 | 13 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2002 | 320 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 391 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 829 | 0.050 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 2 | 1998 | 32 | 0.050 |
Why?
|
Parasympathetic Nervous System | 2 | 1992 | 141 | 0.050 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 494 | 0.050 |
Why?
|
Cerebrospinal Fluid | 2 | 2022 | 534 | 0.050 |
Why?
|
Sesquiterpenes | 1 | 2002 | 177 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2000 | 14722 | 0.050 |
Why?
|
Peroxidases | 1 | 1981 | 138 | 0.050 |
Why?
|
Arachidonic Acids | 3 | 1980 | 299 | 0.050 |
Why?
|
Nitroprusside | 3 | 2001 | 275 | 0.050 |
Why?
|
Binding, Competitive | 3 | 1999 | 1157 | 0.050 |
Why?
|
Phosphorylation | 5 | 2018 | 8436 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4933 | 0.050 |
Why?
|
Hemoglobins | 2 | 2007 | 1534 | 0.050 |
Why?
|
Prognosis | 6 | 1999 | 29063 | 0.050 |
Why?
|
Positive-Pressure Respiration | 2 | 1995 | 633 | 0.050 |
Why?
|
Phospholipases A | 2 | 1997 | 216 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha | 2 | 1980 | 149 | 0.050 |
Why?
|
Endothelial Cells | 3 | 2009 | 3479 | 0.050 |
Why?
|
Calcium | 6 | 2005 | 5756 | 0.050 |
Why?
|
Cost of Illness | 1 | 2010 | 1859 | 0.050 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2000 | 6 | 0.050 |
Why?
|
Lateral Ventricles | 2 | 2016 | 146 | 0.050 |
Why?
|
Anticholesteremic Agents | 2 | 2006 | 979 | 0.050 |
Why?
|
Endothelium | 3 | 1996 | 778 | 0.050 |
Why?
|
Caspase 9 | 1 | 2000 | 188 | 0.050 |
Why?
|
Hot Temperature | 3 | 1997 | 1354 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1995 | 3923 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2003 | 690 | 0.050 |
Why?
|
Adolescent | 10 | 2020 | 85781 | 0.050 |
Why?
|
Receptors, AMPA | 2 | 2000 | 331 | 0.050 |
Why?
|
Erythropoietin | 1 | 2005 | 726 | 0.050 |
Why?
|
Carbohydrates | 1 | 2002 | 394 | 0.050 |
Why?
|
Disease | 1 | 1986 | 680 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7149 | 0.050 |
Why?
|
Caspase 8 | 1 | 2000 | 195 | 0.050 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 752 | 0.050 |
Why?
|
Levodopa | 3 | 1979 | 219 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2000 | 235 | 0.040 |
Why?
|
Climacteric | 1 | 1999 | 57 | 0.040 |
Why?
|
Isoflurane | 2 | 2008 | 380 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2001 | 383 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2008 | 1708 | 0.040 |
Why?
|
Receptors, Adrenergic, beta | 2 | 1980 | 246 | 0.040 |
Why?
|
Alleles | 1 | 2011 | 6933 | 0.040 |
Why?
|
Sulfur Radioisotopes | 2 | 1997 | 116 | 0.040 |
Why?
|
Animals, Newborn | 5 | 1993 | 2726 | 0.040 |
Why?
|
Prostatectomy | 3 | 1995 | 1890 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4420 | 0.040 |
Why?
|
Dexamethasone | 2 | 2002 | 1951 | 0.040 |
Why?
|
Reimbursement Mechanisms | 1 | 1985 | 670 | 0.040 |
Why?
|
Necrosis | 2 | 2008 | 1643 | 0.040 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1999 | 58 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2006 | 1730 | 0.040 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1990 | 115 | 0.040 |
Why?
|
Acute-Phase Reaction | 1 | 1999 | 91 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1454 | 0.040 |
Why?
|
Tetrahydronaphthalenes | 2 | 1997 | 89 | 0.040 |
Why?
|
Culture Techniques | 2 | 1973 | 554 | 0.040 |
Why?
|
Blood Platelets | 2 | 2008 | 2508 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 1999 | 109 | 0.040 |
Why?
|
Information Services | 2 | 1998 | 244 | 0.040 |
Why?
|
Brain Injury, Chronic | 1 | 1999 | 68 | 0.040 |
Why?
|
Hyperbaric Oxygenation | 1 | 2000 | 163 | 0.040 |
Why?
|
Histocytochemistry | 4 | 1997 | 719 | 0.040 |
Why?
|
Receptors, Kainic Acid | 1 | 1999 | 88 | 0.040 |
Why?
|
Depression, Chemical | 2 | 1998 | 191 | 0.040 |
Why?
|
Manipulation, Orthopedic | 1 | 1999 | 43 | 0.040 |
Why?
|
Medicine, Traditional | 1 | 1999 | 91 | 0.040 |
Why?
|
Benzopyrans | 1 | 1999 | 64 | 0.040 |
Why?
|
Women's Health Services | 1 | 1999 | 93 | 0.040 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 32 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2006 | 2938 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2003 | 1341 | 0.040 |
Why?
|
Lysergic Acid Diethylamide | 1 | 1998 | 48 | 0.040 |
Why?
|
Institutional Practice | 1 | 1998 | 17 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2004 | 1222 | 0.040 |
Why?
|
Cerebellum | 4 | 2013 | 1488 | 0.040 |
Why?
|
Dihydroxytryptamines | 1 | 1978 | 6 | 0.040 |
Why?
|
Survival Rate | 3 | 2000 | 12788 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2002 | 535 | 0.040 |
Why?
|
Injections, Intraperitoneal | 1 | 1999 | 425 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1999 | 112 | 0.040 |
Why?
|
Deoxyuracil Nucleotides | 1 | 1998 | 13 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2420 | 0.040 |
Why?
|
Materials Testing | 1 | 2002 | 867 | 0.040 |
Why?
|
Blood | 3 | 1992 | 598 | 0.040 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2000 | 1462 | 0.040 |
Why?
|
Fellowships and Scholarships | 2 | 2001 | 1076 | 0.040 |
Why?
|
Actins | 3 | 2001 | 2121 | 0.040 |
Why?
|
DNA | 5 | 2004 | 7301 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2007 | 528 | 0.040 |
Why?
|
Oxides | 2 | 2001 | 405 | 0.040 |
Why?
|
Colorectal Neoplasms | 2 | 2001 | 6773 | 0.040 |
Why?
|
Quinuclidinyl Benzilate | 1 | 1998 | 19 | 0.040 |
Why?
|
Staining and Labeling | 2 | 1998 | 1100 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2000 | 207 | 0.040 |
Why?
|
Hypertonic Solutions | 1 | 1998 | 93 | 0.040 |
Why?
|
Meningitis, Aseptic | 1 | 2018 | 58 | 0.040 |
Why?
|
Dietary Fats | 3 | 1992 | 2017 | 0.040 |
Why?
|
Sampling Studies | 2 | 1991 | 623 | 0.040 |
Why?
|
Hypertension, Malignant | 1 | 1998 | 19 | 0.040 |
Why?
|
Tetanus Antitoxin | 3 | 1989 | 8 | 0.040 |
Why?
|
Receptors, Histamine | 2 | 1992 | 22 | 0.040 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2018 | 40 | 0.040 |
Why?
|
Flavonoids | 2 | 1999 | 443 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 1997 | 33 | 0.040 |
Why?
|
Motor Cortex | 3 | 2013 | 986 | 0.040 |
Why?
|
Chloral Hydrate | 1 | 1997 | 29 | 0.040 |
Why?
|
Gold Sodium Thiomalate | 2 | 1988 | 10 | 0.040 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 70 | 0.040 |
Why?
|
Hospitals, Teaching | 3 | 1992 | 1179 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 1434 | 0.040 |
Why?
|
Drug Carriers | 1 | 2002 | 693 | 0.040 |
Why?
|
Neurokinin A | 2 | 1987 | 32 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2019 | 8037 | 0.040 |
Why?
|
Saline Solution, Hypertonic | 1 | 1998 | 110 | 0.040 |
Why?
|
Patient Simulation | 2 | 1997 | 309 | 0.040 |
Why?
|
Syndrome | 2 | 2002 | 3251 | 0.040 |
Why?
|
Denervation | 4 | 1993 | 278 | 0.040 |
Why?
|
Cost Allocation | 1 | 1997 | 51 | 0.040 |
Why?
|
Models, Organizational | 1 | 2001 | 574 | 0.040 |
Why?
|
Calibration | 1 | 2000 | 816 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 1998 | 156 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 1998 | 2274 | 0.040 |
Why?
|
Wisconsin | 2 | 1996 | 124 | 0.040 |
Why?
|
Tryptamines | 1 | 1997 | 88 | 0.040 |
Why?
|
Kainic Acid | 1 | 1997 | 199 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 1995 | 3508 | 0.040 |
Why?
|
Meglumine | 1 | 1998 | 149 | 0.040 |
Why?
|
Carbazoles | 1 | 1999 | 226 | 0.040 |
Why?
|
Income | 2 | 1996 | 1913 | 0.040 |
Why?
|
Methyltransferases | 1 | 2000 | 367 | 0.040 |
Why?
|
Tetanus Toxoid | 3 | 1989 | 193 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 3 | 1990 | 3712 | 0.040 |
Why?
|
Transfection | 2 | 2002 | 5892 | 0.040 |
Why?
|
Leucine | 3 | 1976 | 561 | 0.040 |
Why?
|
Aspirin | 1 | 1989 | 3282 | 0.040 |
Why?
|
Breast | 2 | 1984 | 1969 | 0.040 |
Why?
|
Fluorobenzenes | 1 | 1999 | 183 | 0.040 |
Why?
|
Cathepsin B | 1 | 1997 | 82 | 0.040 |
Why?
|
Palliative Care | 2 | 2002 | 3493 | 0.040 |
Why?
|
Kinetics | 6 | 2012 | 6473 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2003 | 2440 | 0.040 |
Why?
|
Prevalence | 4 | 1997 | 15226 | 0.040 |
Why?
|
Radioligand Assay | 1 | 1997 | 374 | 0.040 |
Why?
|
Proteins | 4 | 2002 | 6103 | 0.040 |
Why?
|
Reserpine | 2 | 1975 | 66 | 0.040 |
Why?
|
Models, Animal | 1 | 2003 | 2171 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2000 | 1005 | 0.040 |
Why?
|
Biopsy | 8 | 1984 | 6756 | 0.040 |
Why?
|
Aging | 3 | 2007 | 8664 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 648 | 0.040 |
Why?
|
Choroid Plexus | 1 | 1979 | 231 | 0.040 |
Why?
|
Recombinant Proteins | 4 | 2007 | 6622 | 0.040 |
Why?
|
Rabbits | 4 | 2003 | 4894 | 0.040 |
Why?
|
Breast Diseases | 1 | 1980 | 443 | 0.040 |
Why?
|
Family Health | 1 | 2001 | 1282 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2001 | 725 | 0.040 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2006 | 57 | 0.040 |
Why?
|
Monte Carlo Method | 2 | 1999 | 1254 | 0.040 |
Why?
|
Cholesterol | 4 | 2001 | 2917 | 0.030 |
Why?
|
Fracture Fixation | 1 | 1999 | 354 | 0.030 |
Why?
|
Xeromammography | 3 | 1986 | 21 | 0.030 |
Why?
|
Frail Elderly | 1 | 2001 | 693 | 0.030 |
Why?
|
Nitriles | 1 | 2001 | 956 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2000 | 397 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 1995 | 1873 | 0.030 |
Why?
|
Cohort Studies | 5 | 2000 | 40561 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2012 | 3445 | 0.030 |
Why?
|
Hypoventilation | 1 | 1976 | 38 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1998 | 1095 | 0.030 |
Why?
|
Muscimol | 1 | 1995 | 69 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 1996 | 206 | 0.030 |
Why?
|
Inositol | 2 | 1987 | 218 | 0.030 |
Why?
|
Receptors, Cholinergic | 2 | 1980 | 238 | 0.030 |
Why?
|
Spleen | 2 | 2012 | 2362 | 0.030 |
Why?
|
Videotape Recording | 1 | 1997 | 352 | 0.030 |
Why?
|
Patient Readmission | 2 | 1999 | 3114 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2019 | 553 | 0.030 |
Why?
|
Adoptive Transfer | 2 | 2012 | 844 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1995 | 62 | 0.030 |
Why?
|
Microdialysis | 3 | 2001 | 158 | 0.030 |
Why?
|
Cell Adhesion | 3 | 2011 | 3144 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 1996 | 259 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2001 | 3396 | 0.030 |
Why?
|
Organ Specificity | 2 | 1998 | 2008 | 0.030 |
Why?
|
Biomedical Research | 2 | 2013 | 3309 | 0.030 |
Why?
|
GABA-A Receptor Agonists | 1 | 1995 | 84 | 0.030 |
Why?
|
Neural Conduction | 1 | 1997 | 440 | 0.030 |
Why?
|
SEER Program | 1 | 2000 | 1508 | 0.030 |
Why?
|
Cisterna Magna | 1 | 1995 | 41 | 0.030 |
Why?
|
Maze Learning | 2 | 2008 | 478 | 0.030 |
Why?
|
Urination Disorders | 1 | 1996 | 241 | 0.030 |
Why?
|
Retinitis Pigmentosa | 1 | 1999 | 386 | 0.030 |
Why?
|
GABA Agonists | 1 | 1995 | 111 | 0.030 |
Why?
|
Sympathetic Nervous System | 4 | 1985 | 514 | 0.030 |
Why?
|
Adrenergic Fibers | 1 | 2014 | 21 | 0.030 |
Why?
|
Neostriatum | 1 | 2016 | 250 | 0.030 |
Why?
|
Agglutination | 2 | 1964 | 43 | 0.030 |
Why?
|
Cataract | 1 | 2001 | 834 | 0.030 |
Why?
|
Forecasting | 3 | 1991 | 2951 | 0.030 |
Why?
|
Receptors, Drug | 1 | 1975 | 160 | 0.030 |
Why?
|
Vaccines | 1 | 2003 | 822 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 703 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 3 | 1991 | 1375 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2014 | 63 | 0.030 |
Why?
|
Reaction Time | 2 | 2017 | 2097 | 0.030 |
Why?
|
Pituitary Diseases | 1 | 1976 | 141 | 0.030 |
Why?
|
Streptomycin | 2 | 1965 | 69 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2004 | 2161 | 0.030 |
Why?
|
Common Bile Duct | 1 | 1995 | 109 | 0.030 |
Why?
|
Clinical Protocols | 2 | 1992 | 1462 | 0.030 |
Why?
|
Hospital Information Systems | 1 | 1997 | 395 | 0.030 |
Why?
|
Protein Binding | 3 | 2007 | 9386 | 0.030 |
Why?
|
Risk Management | 1 | 1998 | 571 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1917 | 0.030 |
Why?
|
Receptor, Serotonin, 5-HT1D | 3 | 1999 | 9 | 0.030 |
Why?
|
Alanine | 3 | 2007 | 572 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2003 | 3206 | 0.030 |
Why?
|
Apnea | 1 | 1976 | 195 | 0.030 |
Why?
|
Office Visits | 1 | 1998 | 598 | 0.030 |
Why?
|
Coloring Agents | 3 | 2001 | 566 | 0.030 |
Why?
|
New York | 1 | 1997 | 886 | 0.030 |
Why?
|
Aneurysm, Infected | 1 | 1974 | 85 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2001 | 2453 | 0.030 |
Why?
|
Serum Albumin, Radio-Iodinated | 2 | 1991 | 37 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3778 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1998 | 665 | 0.030 |
Why?
|
Dipeptides | 1 | 1996 | 409 | 0.030 |
Why?
|
Nervous System | 2 | 1989 | 554 | 0.030 |
Why?
|
New England | 1 | 1997 | 1022 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 514 | 0.030 |
Why?
|
Isotope Labeling | 1 | 1995 | 406 | 0.030 |
Why?
|
Information Systems | 1 | 1996 | 410 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.030 |
Why?
|
Substantia Nigra | 1 | 1995 | 353 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2014 | 375 | 0.030 |
Why?
|
Chronic Disease | 2 | 2013 | 9146 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 1997 | 634 | 0.030 |
Why?
|
Methylhistamines | 1 | 1992 | 4 | 0.030 |
Why?
|
Cause of Death | 2 | 2001 | 3584 | 0.030 |
Why?
|
Reimbursement, Incentive | 1 | 1998 | 540 | 0.030 |
Why?
|
Histamine Agonists | 1 | 1992 | 11 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1990 | 4258 | 0.030 |
Why?
|
Liver | 4 | 2004 | 7474 | 0.030 |
Why?
|
Carotid Artery, Internal | 2 | 2007 | 445 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 1994 | 379 | 0.030 |
Why?
|
Patient Selection | 1 | 2005 | 4215 | 0.030 |
Why?
|
Follow-Up Studies | 6 | 2000 | 39050 | 0.030 |
Why?
|
Goals | 1 | 1998 | 706 | 0.030 |
Why?
|
Physical Exertion | 1 | 1976 | 695 | 0.030 |
Why?
|
Models, Economic | 1 | 1997 | 713 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1994 | 1085 | 0.030 |
Why?
|
Serine | 3 | 2007 | 826 | 0.030 |
Why?
|
Registries | 2 | 1999 | 8089 | 0.030 |
Why?
|
Skin | 2 | 1986 | 4364 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2007 | 2050 | 0.030 |
Why?
|
Respiration | 2 | 1999 | 1653 | 0.030 |
Why?
|
Sensory Deprivation | 1 | 1993 | 109 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2072 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 1977 | 671 | 0.030 |
Why?
|
American Cancer Society | 1 | 1992 | 61 | 0.030 |
Why?
|
Tibia | 1 | 2018 | 1077 | 0.030 |
Why?
|
Image Enhancement | 2 | 2001 | 2921 | 0.030 |
Why?
|
Prospective Studies | 9 | 1999 | 53288 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3420 | 0.030 |
Why?
|
Catalase | 1 | 1992 | 222 | 0.030 |
Why?
|
Molecular Conformation | 1 | 1993 | 563 | 0.030 |
Why?
|
Octreotide | 1 | 1992 | 145 | 0.030 |
Why?
|
Femoral Artery | 2 | 2008 | 845 | 0.030 |
Why?
|
Administration, Oral | 2 | 2003 | 3913 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1992 | 177 | 0.030 |
Why?
|
Achievement | 1 | 1993 | 291 | 0.030 |
Why?
|
Benzamides | 1 | 1997 | 1379 | 0.030 |
Why?
|
Injections | 1 | 1995 | 840 | 0.030 |
Why?
|
Rehabilitation | 1 | 1993 | 134 | 0.030 |
Why?
|
Prostaglandin D2 | 2 | 1989 | 122 | 0.030 |
Why?
|
Anesthetics, Inhalation | 1 | 1997 | 570 | 0.030 |
Why?
|
Iron | 2 | 2001 | 1774 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2001 | 3200 | 0.030 |
Why?
|
Respiration, Artificial | 2 | 1995 | 2569 | 0.030 |
Why?
|
Calcinosis | 3 | 1983 | 1499 | 0.030 |
Why?
|
Cranial Nerve Diseases | 1 | 1992 | 112 | 0.030 |
Why?
|
Superoxides | 1 | 1992 | 387 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 726 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 1994 | 1105 | 0.020 |
Why?
|
Factor Analysis, Statistical | 3 | 1999 | 977 | 0.020 |
Why?
|
Periaqueductal Gray | 2 | 1989 | 107 | 0.020 |
Why?
|
Immune Sera | 4 | 1986 | 641 | 0.020 |
Why?
|
Amyloid beta-Peptides | 2 | 2019 | 3587 | 0.020 |
Why?
|
Stem Cell Niche | 1 | 2014 | 346 | 0.020 |
Why?
|
Disability Evaluation | 1 | 1998 | 1827 | 0.020 |
Why?
|
Hypothalamus | 2 | 1978 | 1063 | 0.020 |
Why?
|
Vacuoles | 1 | 1992 | 230 | 0.020 |
Why?
|
Lipids | 1 | 2002 | 3305 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2001 | 2266 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3768 | 0.020 |
Why?
|
Phenylketonurias | 3 | 1979 | 122 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 1995 | 686 | 0.020 |
Why?
|
Thymidine | 2 | 1986 | 310 | 0.020 |
Why?
|
Drug Design | 1 | 1996 | 1076 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 6489 | 0.020 |
Why?
|
Gadolinium DTPA | 2 | 2008 | 836 | 0.020 |
Why?
|
Psychological Tests | 1 | 1993 | 651 | 0.020 |
Why?
|
Hip Prosthesis | 1 | 1997 | 917 | 0.020 |
Why?
|
Infertility | 1 | 1997 | 655 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2002 | 3086 | 0.020 |
Why?
|
Radiology Information Systems | 1 | 1995 | 523 | 0.020 |
Why?
|
Mental Recall | 1 | 1997 | 1205 | 0.020 |
Why?
|
Neutrophils | 2 | 2018 | 3719 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1995 | 2557 | 0.020 |
Why?
|
Spectrophotometry | 2 | 2005 | 313 | 0.020 |
Why?
|
Bone Resorption | 1 | 1994 | 723 | 0.020 |
Why?
|
Demography | 1 | 1995 | 1656 | 0.020 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1989 | 60 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 1993 | 414 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 1992 | 326 | 0.020 |
Why?
|
Cell Line | 5 | 2005 | 15997 | 0.020 |
Why?
|
Morbidity | 2 | 2001 | 1769 | 0.020 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 2 | 2000 | 45 | 0.020 |
Why?
|
Cytoplasmic Granules | 2 | 1991 | 610 | 0.020 |
Why?
|
Posture | 1 | 1994 | 958 | 0.020 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 1989 | 67 | 0.020 |
Why?
|
Heart Failure | 3 | 2000 | 10900 | 0.020 |
Why?
|
Interviews as Topic | 2 | 1998 | 2539 | 0.020 |
Why?
|
Arachidonate Lipoxygenases | 1 | 1989 | 19 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2011 | 235 | 0.020 |
Why?
|
Arthritis | 2 | 1985 | 659 | 0.020 |
Why?
|
Terminal Care | 1 | 2001 | 1694 | 0.020 |
Why?
|
Sequence Alignment | 1 | 1994 | 2256 | 0.020 |
Why?
|
Ambulatory Care Information Systems | 1 | 1989 | 86 | 0.020 |
Why?
|
Aspartic Acid | 2 | 2007 | 576 | 0.020 |
Why?
|
Fever | 1 | 1977 | 1616 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2000 | 122 | 0.020 |
Why?
|
Forelimb | 2 | 1999 | 122 | 0.020 |
Why?
|
RNA | 3 | 1989 | 2749 | 0.020 |
Why?
|
Observer Variation | 2 | 1992 | 2593 | 0.020 |
Why?
|
Radiography | 3 | 2013 | 7023 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 315 | 0.020 |
Why?
|
Nucleoproteins | 2 | 1973 | 115 | 0.020 |
Why?
|
Annexin A5 | 1 | 2009 | 103 | 0.020 |
Why?
|
Agranulocytosis | 1 | 1988 | 101 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 152 | 0.020 |
Why?
|
Disease Progression | 2 | 2003 | 13284 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1989 | 94 | 0.020 |
Why?
|
Insurance, Health | 1 | 2001 | 2494 | 0.020 |
Why?
|
Cross-Sectional Studies | 4 | 2013 | 25043 | 0.020 |
Why?
|
Bleeding Time | 1 | 2008 | 89 | 0.020 |
Why?
|
Cholecystokinin | 1 | 1989 | 114 | 0.020 |
Why?
|
Ornithine | 1 | 2008 | 78 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1995 | 1082 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 15165 | 0.020 |
Why?
|
Outpatients | 1 | 1996 | 1486 | 0.020 |
Why?
|
Survivors | 1 | 1999 | 2291 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1998 | 1956 | 0.020 |
Why?
|
Cytokines | 4 | 2005 | 7322 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1801 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 3002 | 0.020 |
Why?
|
Leukotriene Antagonists | 1 | 1989 | 127 | 0.020 |
Why?
|
Geriatrics | 1 | 1993 | 396 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2000 | 234 | 0.020 |
Why?
|
Chemistry | 2 | 1989 | 352 | 0.020 |
Why?
|
Mitogens | 2 | 1986 | 232 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6386 | 0.020 |
Why?
|
Vertebral Artery | 1 | 1989 | 192 | 0.020 |
Why?
|
Health Personnel | 1 | 2001 | 3218 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2008 | 719 | 0.020 |
Why?
|
Chemical Phenomena | 2 | 1989 | 518 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 1992 | 780 | 0.020 |
Why?
|
Motivation | 1 | 1998 | 1971 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 1991 | 1144 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2009 | 237 | 0.020 |
Why?
|
Busulfan | 1 | 1988 | 263 | 0.020 |
Why?
|
Retina | 1 | 1999 | 2616 | 0.020 |
Why?
|
Alcohol Drinking | 2 | 1993 | 3966 | 0.020 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2008 | 176 | 0.020 |
Why?
|
Mitral Valve Prolapse | 1 | 1989 | 231 | 0.020 |
Why?
|
DNA Damage | 1 | 1997 | 2432 | 0.020 |
Why?
|
Veterans | 1 | 2001 | 2519 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1009 | 0.020 |
Why?
|
Veratrum Alkaloids | 1 | 2007 | 25 | 0.020 |
Why?
|
ROC Curve | 2 | 1993 | 3527 | 0.020 |
Why?
|
Sympathectomy, Chemical | 1 | 1987 | 22 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 1999 | 642 | 0.020 |
Why?
|
RNA Probes | 1 | 2007 | 113 | 0.020 |
Why?
|
False Positive Reactions | 2 | 1983 | 981 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2007 | 135 | 0.020 |
Why?
|
New Mexico | 1 | 1987 | 86 | 0.020 |
Why?
|
Phenylephrine | 1 | 2008 | 301 | 0.020 |
Why?
|
Nitrous Oxide | 1 | 2008 | 177 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 3870 | 0.020 |
Why?
|
Coma | 1 | 2011 | 475 | 0.020 |
Why?
|
Lithium Chloride | 1 | 1987 | 87 | 0.020 |
Why?
|
Orchiectomy | 1 | 2009 | 474 | 0.020 |
Why?
|
Ferrosoferric Oxide | 2 | 2001 | 360 | 0.020 |
Why?
|
Atropine | 1 | 1987 | 244 | 0.020 |
Why?
|
Biological Assay | 3 | 1980 | 652 | 0.020 |
Why?
|
Hospitals, University | 1 | 1989 | 571 | 0.020 |
Why?
|
Risk Assessment | 2 | 1999 | 23338 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1989 | 623 | 0.020 |
Why?
|
Oxidopamine | 1 | 1987 | 169 | 0.020 |
Why?
|
Clostridium perfringens | 2 | 1958 | 27 | 0.020 |
Why?
|
Neural Inhibition | 2 | 2008 | 602 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1836 | 0.020 |
Why?
|
Haplorhini | 2 | 1966 | 552 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1285 | 0.020 |
Why?
|
Autonomic Fibers, Postganglionic | 1 | 1986 | 5 | 0.020 |
Why?
|
Bombesin | 1 | 1986 | 34 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2012 | 1438 | 0.020 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 1987 | 94 | 0.020 |
Why?
|
Obesity | 1 | 2009 | 12745 | 0.020 |
Why?
|
Health Status Indicators | 1 | 1992 | 969 | 0.020 |
Why?
|
Receptors, Bradykinin | 1 | 1986 | 19 | 0.020 |
Why?
|
Dinoprostone | 1 | 1989 | 600 | 0.020 |
Why?
|
Systems Integration | 1 | 2008 | 440 | 0.020 |
Why?
|
Self-Assessment | 3 | 1993 | 390 | 0.020 |
Why?
|
Language | 1 | 1996 | 1471 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 1999 | 2538 | 0.020 |
Why?
|
Ovariectomy | 1 | 2008 | 661 | 0.020 |
Why?
|
Microspheres | 2 | 2004 | 777 | 0.020 |
Why?
|
Death, Sudden | 1 | 1988 | 302 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2967 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 972 | 0.020 |
Why?
|
Mitochondrial Swelling | 1 | 2005 | 17 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1549 | 0.020 |
Why?
|
DNA Methylation | 1 | 2000 | 4286 | 0.020 |
Why?
|
Residence Characteristics | 1 | 1996 | 2050 | 0.020 |
Why?
|
Cyclic AMP | 3 | 1997 | 1472 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2599 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1986 | 180 | 0.020 |
Why?
|
Homovanillic Acid | 2 | 1975 | 75 | 0.020 |
Why?
|
Hypoxia, Brain | 1 | 2006 | 133 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 767 | 0.020 |
Why?
|
Tauopathies | 1 | 2009 | 307 | 0.020 |
Why?
|
Diagnostic Imaging | 2 | 2003 | 3507 | 0.020 |
Why?
|
Pediatrics | 1 | 2001 | 3475 | 0.020 |
Why?
|
Platelet Count | 1 | 1988 | 781 | 0.020 |
Why?
|
Brain Diseases | 3 | 2005 | 1563 | 0.020 |
Why?
|
Delphi Technique | 1 | 1989 | 778 | 0.020 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2005 | 49 | 0.020 |
Why?
|
Trigeminal Neuralgia | 1 | 1987 | 113 | 0.020 |
Why?
|
Adenine | 1 | 2011 | 936 | 0.020 |
Why?
|
Propranolol | 1 | 1987 | 502 | 0.020 |
Why?
|
Peripheral Nerves | 2 | 1986 | 466 | 0.020 |
Why?
|
Algorithms | 4 | 2009 | 13881 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1987 | 301 | 0.020 |
Why?
|
Partial Pressure | 2 | 1997 | 254 | 0.020 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 38 | 0.020 |
Why?
|
Antitoxins | 2 | 1955 | 81 | 0.020 |
Why?
|
Immune Tolerance | 2 | 2005 | 2258 | 0.020 |
Why?
|
Forehead | 1 | 1985 | 69 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2007 | 472 | 0.020 |
Why?
|
Intracranial Aneurysm | 1 | 1974 | 1197 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2005 | 153 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2007 | 374 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 677 | 0.020 |
Why?
|
Avidin | 1 | 1985 | 44 | 0.020 |
Why?
|
Transforming Growth Factors | 1 | 1985 | 76 | 0.020 |
Why?
|
Body Temperature | 2 | 1999 | 777 | 0.020 |
Why?
|
Diagnosis | 1 | 1986 | 154 | 0.020 |
Why?
|
Thalamus | 1 | 2011 | 1023 | 0.020 |
Why?
|
Motor Skills | 1 | 2008 | 522 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2005 | 433 | 0.020 |
Why?
|
Pharmacology | 1 | 1965 | 103 | 0.020 |
Why?
|
Cranial Nerves | 1 | 1985 | 101 | 0.020 |
Why?
|
Hydrolysis | 1 | 1986 | 682 | 0.020 |
Why?
|
Ohio | 2 | 1983 | 337 | 0.020 |
Why?
|
Wheat Germ Agglutinins | 1 | 1984 | 47 | 0.020 |
Why?
|
Cystine | 1 | 1965 | 95 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2006 | 494 | 0.020 |
Why?
|
Genetic Code | 1 | 1965 | 154 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1988 | 1588 | 0.020 |
Why?
|
Microscopy, Fluorescence | 2 | 1983 | 2699 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 1990 | 879 | 0.020 |
Why?
|
Chlorides | 1 | 1987 | 667 | 0.020 |
Why?
|
Hyperplasia | 2 | 1980 | 1185 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2005 | 462 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.020 |
Why?
|
Radiology | 1 | 1998 | 2100 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 1988 | 607 | 0.020 |
Why?
|
Sulfur Isotopes | 1 | 2004 | 24 | 0.020 |
Why?
|
Research Personnel | 1 | 1989 | 573 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 193 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2018 | 20129 | 0.020 |
Why?
|
Catheterization | 1 | 1990 | 1470 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2886 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 1999 | 12354 | 0.020 |
Why?
|
Toxicology | 1 | 1965 | 106 | 0.020 |
Why?
|
Dihydrostreptomycin Sulfate | 1 | 1963 | 1 | 0.020 |
Why?
|
Genes | 1 | 1988 | 1893 | 0.020 |
Why?
|
Genetics | 1 | 1965 | 112 | 0.020 |
Why?
|
Somatostatin | 1 | 1986 | 459 | 0.010 |
Why?
|
Ophthalmic Nerve | 1 | 1984 | 43 | 0.010 |
Why?
|
Tail | 1 | 2004 | 97 | 0.010 |
Why?
|
Lithium | 1 | 1987 | 601 | 0.010 |
Why?
|
Patient Transfer | 1 | 1991 | 761 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2007 | 504 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.010 |
Why?
|
Homozygote | 2 | 1999 | 1785 | 0.010 |
Why?
|
Carcinoma | 1 | 1975 | 2375 | 0.010 |
Why?
|
Trypsin | 1 | 1964 | 511 | 0.010 |
Why?
|
Body Weight | 3 | 1992 | 4669 | 0.010 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2008 | 687 | 0.010 |
Why?
|
Suramin | 1 | 2003 | 34 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1990 | 788 | 0.010 |
Why?
|
Statistics as Topic | 2 | 1988 | 2373 | 0.010 |
Why?
|
Receptors, Lysophospholipid | 1 | 2003 | 39 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1581 | 0.010 |
Why?
|
Feeding Behavior | 2 | 1993 | 3188 | 0.010 |
Why?
|
Formaldehyde | 2 | 1992 | 353 | 0.010 |
Why?
|
Hepatic Encephalopathy | 2 | 1975 | 139 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 1995 | 1432 | 0.010 |
Why?
|
Citrates | 1 | 1963 | 131 | 0.010 |
Why?
|
Hand | 1 | 2009 | 884 | 0.010 |
Why?
|
Spinal Cord Injuries | 3 | 1978 | 931 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 2 | 1999 | 1240 | 0.010 |
Why?
|
Postoperative Period | 1 | 1988 | 1842 | 0.010 |
Why?
|
Body Mass Index | 1 | 2001 | 12720 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 712 | 0.010 |
Why?
|
Mice, Congenic | 1 | 2003 | 99 | 0.010 |
Why?
|
Autopsy | 1 | 1987 | 1020 | 0.010 |
Why?
|
Hormones | 2 | 1977 | 889 | 0.010 |
Why?
|
Bone and Bones | 1 | 1994 | 2575 | 0.010 |
Why?
|
Permeability | 1 | 2005 | 738 | 0.010 |
Why?
|
Parkinson Disease | 3 | 2009 | 2775 | 0.010 |
Why?
|
Health Status | 4 | 1999 | 4034 | 0.010 |
Why?
|
Microelectrodes | 1 | 2004 | 303 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 1987 | 417 | 0.010 |
Why?
|
Chimera | 1 | 2004 | 485 | 0.010 |
Why?
|
Brain Infarction | 1 | 2005 | 299 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 365 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1983 | 218 | 0.010 |
Why?
|
Arthritis, Experimental | 1 | 1985 | 291 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2007 | 1950 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 2004 | 269 | 0.010 |
Why?
|
Cell Biology | 1 | 1963 | 92 | 0.010 |
Why?
|
Sleep | 3 | 1994 | 4623 | 0.010 |
Why?
|
Models, Immunological | 1 | 2005 | 527 | 0.010 |
Why?
|
Glycine | 2 | 1998 | 671 | 0.010 |
Why?
|
p-Chloroamphetamine | 2 | 1979 | 7 | 0.010 |
Why?
|
O Antigens | 1 | 2004 | 193 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1129 | 0.010 |
Why?
|
Metal Nanoparticles | 1 | 2007 | 405 | 0.010 |
Why?
|
Heparin | 1 | 1990 | 1637 | 0.010 |
Why?
|
Amides | 1 | 2005 | 459 | 0.010 |
Why?
|
Sulfates | 1 | 1963 | 390 | 0.010 |
Why?
|
Feasibility Studies | 4 | 1997 | 5078 | 0.010 |
Why?
|
Motor Neurons | 2 | 1998 | 844 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2003 | 446 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1986 | 2645 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2009 | 1406 | 0.010 |
Why?
|
Cell Separation | 1 | 2008 | 1751 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 2004 | 354 | 0.010 |
Why?
|
Calpain | 1 | 2002 | 150 | 0.010 |
Why?
|
Eating | 1 | 2009 | 1536 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1990 | 1179 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 731 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 506 | 0.010 |
Why?
|
Genes, p53 | 1 | 2004 | 755 | 0.010 |
Why?
|
Sirolimus | 1 | 2009 | 1564 | 0.010 |
Why?
|
Peptide Chain Elongation, Translational | 2 | 1978 | 33 | 0.010 |
Why?
|
Management Information Systems | 1 | 2001 | 50 | 0.010 |
Why?
|
Nanotechnology | 1 | 2007 | 710 | 0.010 |
Why?
|
Hematoxylin | 1 | 2001 | 64 | 0.010 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2001 | 72 | 0.010 |
Why?
|
Nucleic Acids | 1 | 1963 | 182 | 0.010 |
Why?
|
Polyvinyl Alcohol | 1 | 1981 | 74 | 0.010 |
Why?
|
Occult Blood | 1 | 2001 | 176 | 0.010 |
Why?
|
Erythrocytes | 3 | 1957 | 2455 | 0.010 |
Why?
|
Cricetinae | 1 | 1985 | 2472 | 0.010 |
Why?
|
Seizures | 2 | 1989 | 2859 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1980 | 90 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2001 | 352 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 18111 | 0.010 |
Why?
|
Diagnostic Errors | 3 | 1983 | 1257 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2003 | 433 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1983 | 915 | 0.010 |
Why?
|
Electrocardiography | 1 | 1994 | 6442 | 0.010 |
Why?
|
Tretinoin | 1 | 1984 | 517 | 0.010 |
Why?
|
Circadian Rhythm | 3 | 1978 | 2624 | 0.010 |
Why?
|
Peptide Chain Initiation, Translational | 2 | 1978 | 103 | 0.010 |
Why?
|
Receptors, Histamine H1 | 1 | 1980 | 18 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 1899 | 0.010 |
Why?
|
COS Cells | 1 | 2002 | 1161 | 0.010 |
Why?
|
Cross Infection | 1 | 1990 | 1416 | 0.010 |
Why?
|
Melitten | 1 | 1980 | 12 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2785 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2585 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 927 | 0.010 |
Why?
|
Bee Venoms | 1 | 1980 | 14 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2004 | 413 | 0.010 |
Why?
|
Caspases, Initiator | 1 | 2000 | 32 | 0.010 |
Why?
|
Lung Diseases | 1 | 1991 | 1886 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 2003 | 490 | 0.010 |
Why?
|
Mitosis | 2 | 1998 | 1208 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6314 | 0.010 |
Why?
|
Magnesium | 1 | 1963 | 813 | 0.010 |
Why?
|
Thromboxanes | 1 | 1979 | 50 | 0.010 |
Why?
|
Tubulin | 1 | 2004 | 695 | 0.010 |
Why?
|
Cysteine | 1 | 1965 | 874 | 0.010 |
Why?
|
Phenylalanine | 2 | 1979 | 365 | 0.010 |
Why?
|
Laminin | 1 | 2001 | 419 | 0.010 |
Why?
|
Fenclonine | 1 | 1979 | 16 | 0.010 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1981 | 209 | 0.010 |
Why?
|
Movement Disorders | 2 | 1975 | 445 | 0.010 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2000 | 129 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 3386 | 0.010 |
Why?
|
src Homology Domains | 1 | 2000 | 364 | 0.010 |
Why?
|
Pindolol | 1 | 1999 | 32 | 0.010 |
Why?
|
Cerebral Veins | 1 | 2001 | 156 | 0.010 |
Why?
|
Genomic Library | 1 | 1999 | 193 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2109 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2001 | 295 | 0.010 |
Why?
|
Compliance | 1 | 1999 | 104 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1979 | 174 | 0.010 |
Why?
|
Tryptophan Hydroxylase | 1 | 1979 | 89 | 0.010 |
Why?
|
Collagenases | 1 | 2000 | 228 | 0.010 |
Why?
|
Ventilation | 1 | 1999 | 127 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2001 | 498 | 0.010 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1979 | 158 | 0.010 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2000 | 241 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 1979 | 295 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 2000 | 229 | 0.010 |
Why?
|
Dopamine Antagonists | 1 | 2000 | 296 | 0.010 |
Why?
|
Telomerase | 1 | 2004 | 730 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1979 | 93 | 0.010 |
Why?
|
Caspase 2 | 1 | 1998 | 27 | 0.010 |
Why?
|
Mastectomy | 1 | 1987 | 1793 | 0.010 |
Why?
|
Amino Acids | 1 | 1965 | 1736 | 0.010 |
Why?
|
Water | 2 | 1998 | 1395 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1547 | 0.010 |
Why?
|
Terminology as Topic | 1 | 1986 | 1547 | 0.010 |
Why?
|
Palpation | 1 | 1978 | 167 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 1981 | 813 | 0.010 |
Why?
|
Cornea | 1 | 1987 | 1524 | 0.010 |
Why?
|
Taurine | 1 | 1998 | 94 | 0.010 |
Why?
|
Swine | 3 | 1995 | 5917 | 0.010 |
Why?
|
Body Temperature Regulation | 1 | 1999 | 252 | 0.010 |
Why?
|
Ethanolamines | 1 | 1998 | 158 | 0.010 |
Why?
|
Hemagglutination | 1 | 1957 | 34 | 0.010 |
Why?
|
Receptors, Dopamine D1 | 1 | 2000 | 291 | 0.010 |
Why?
|
Litter Size | 1 | 1997 | 54 | 0.010 |
Why?
|
Cerebral Angiography | 2 | 1993 | 1285 | 0.010 |
Why?
|
Acetylserotonin O-Methyltransferase | 1 | 1977 | 3 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 1999 | 337 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2003 | 838 | 0.010 |
Why?
|
Edetic Acid | 1 | 1958 | 276 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1701 | 0.010 |
Why?
|
Phospholipases A2 | 1 | 1997 | 203 | 0.010 |
Why?
|
Heart Diseases | 1 | 1991 | 2788 | 0.010 |
Why?
|
Ganglioneuroma | 1 | 1977 | 57 | 0.010 |
Why?
|
Diterpenes | 1 | 1998 | 173 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1994 | 13989 | 0.010 |
Why?
|
Ligation | 3 | 1991 | 453 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1981 | 968 | 0.010 |
Why?
|
Benzazepines | 1 | 2000 | 326 | 0.010 |
Why?
|
Antimetabolites | 1 | 1998 | 125 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1998 | 862 | 0.010 |
Why?
|
Reticulocytes | 1 | 1978 | 290 | 0.010 |
Why?
|
California | 1 | 2001 | 1402 | 0.010 |
Why?
|
Darkness | 1 | 1977 | 167 | 0.010 |
Why?
|
Cyclic N-Oxides | 1 | 1997 | 78 | 0.010 |
Why?
|
Gonads | 1 | 1977 | 109 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2008 | 5974 | 0.010 |
Why?
|
Tryptophan | 1 | 1979 | 478 | 0.010 |
Why?
|
Antigens | 2 | 1955 | 1466 | 0.010 |
Why?
|
Sexual Harassment | 1 | 1998 | 79 | 0.010 |
Why?
|
Paraplegia | 1 | 1978 | 168 | 0.010 |
Why?
|
Nitrogen Oxides | 1 | 1997 | 129 | 0.010 |
Why?
|
Europe | 1 | 1984 | 3339 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2002 | 1240 | 0.010 |
Why?
|
Computer Simulation | 2 | 2006 | 6196 | 0.010 |
Why?
|
Echocardiography | 1 | 1989 | 5102 | 0.010 |
Why?
|
Solubility | 1 | 1998 | 1085 | 0.010 |
Why?
|
Macrophages, Peritoneal | 1 | 1997 | 251 | 0.010 |
Why?
|
Granzymes | 1 | 1998 | 271 | 0.010 |
Why?
|
Capillaries | 1 | 1980 | 773 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2008 | 2899 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1994 | 9274 | 0.010 |
Why?
|
APACHE | 1 | 1997 | 277 | 0.010 |
Why?
|
Magnetics | 1 | 1999 | 606 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1986 | 1790 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 697 | 0.010 |
Why?
|
Chelating Agents | 1 | 1958 | 380 | 0.010 |
Why?
|
Neoplasms | 2 | 2001 | 21683 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.010 |
Why?
|
Internal-External Control | 1 | 1998 | 363 | 0.010 |
Why?
|
Quadriplegia | 1 | 1978 | 223 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1992 | 8428 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1991 | 4245 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2382 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1801 | 0.010 |
Why?
|
Reflex | 2 | 1989 | 365 | 0.010 |
Why?
|
Equipment Design | 1 | 2004 | 3582 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3508 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2046 | 0.010 |
Why?
|
Nerve Endings | 1 | 1975 | 109 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 1679 | 0.010 |
Why?
|
RNA, Transfer | 1 | 1978 | 316 | 0.010 |
Why?
|
Family Relations | 1 | 1998 | 321 | 0.010 |
Why?
|
Spin Labels | 1 | 1997 | 332 | 0.010 |
Why?
|
Pimozide | 1 | 1975 | 21 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3772 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2001 | 1121 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1998 | 1137 | 0.010 |
Why?
|
Science | 1 | 1998 | 241 | 0.010 |
Why?
|
Torticollis | 1 | 1975 | 66 | 0.010 |
Why?
|
Ventricular Pressure | 1 | 1995 | 199 | 0.010 |
Why?
|
Chick Embryo | 1 | 1997 | 982 | 0.010 |
Why?
|
Perception | 1 | 2001 | 1198 | 0.010 |
Why?
|
Software Design | 1 | 1995 | 176 | 0.010 |
Why?
|
Dystonia Musculorum Deformans | 1 | 1975 | 158 | 0.010 |
Why?
|
Diffusion | 1 | 1997 | 833 | 0.010 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1974 | 148 | 0.010 |
Why?
|
Ribosomes | 1 | 1978 | 500 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2001 | 1970 | 0.010 |
Why?
|
Lighting | 1 | 1977 | 231 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1997 | 458 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1966 | 3474 | 0.010 |
Why?
|
Simian virus 40 | 1 | 1975 | 295 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12208 | 0.010 |
Why?
|
Dysautonomia, Familial | 1 | 1975 | 95 | 0.010 |
Why?
|
Efficiency | 1 | 1998 | 462 | 0.010 |
Why?
|
Lymphocytes | 1 | 1982 | 2617 | 0.010 |
Why?
|
Hydroxyproline | 1 | 1994 | 116 | 0.010 |
Why?
|
Antigens, CD | 1 | 2005 | 4026 | 0.010 |
Why?
|
Cytosol | 1 | 1997 | 901 | 0.010 |
Why?
|
Polyomavirus | 1 | 1975 | 248 | 0.010 |
Why?
|
Documentation | 2 | 1992 | 871 | 0.010 |
Why?
|
Carcinoma in Situ | 2 | 1981 | 806 | 0.010 |
Why?
|
Brain Concussion | 1 | 1985 | 1320 | 0.010 |
Why?
|
Magnetite Nanoparticles | 1 | 1996 | 321 | 0.010 |
Why?
|
Dextrans | 1 | 1996 | 595 | 0.010 |
Why?
|
Colonoscopy | 1 | 2001 | 1367 | 0.010 |
Why?
|
Supine Position | 1 | 1994 | 205 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2001 | 1741 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3737 | 0.010 |
Why?
|
Chromatography, Paper | 1 | 1973 | 77 | 0.010 |
Why?
|
Computer Systems | 1 | 1995 | 483 | 0.010 |
Why?
|
Collateral Circulation | 1 | 1974 | 287 | 0.010 |
Why?
|
Percussion | 1 | 1993 | 18 | 0.010 |
Why?
|
Medicaid | 1 | 1987 | 2736 | 0.010 |
Why?
|
Surface Tension | 1 | 1993 | 47 | 0.010 |
Why?
|
Computer Communication Networks | 1 | 1995 | 295 | 0.010 |
Why?
|
Receptors, Histamine H3 | 1 | 1992 | 9 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1981 | 949 | 0.010 |
Why?
|
Joints | 2 | 1985 | 326 | 0.010 |
Why?
|
Retinal Ganglion Cells | 1 | 1999 | 770 | 0.010 |
Why?
|
Energy Intake | 2 | 1992 | 2148 | 0.010 |
Why?
|
Phosphorus | 1 | 1994 | 338 | 0.010 |
Why?
|
Oocytes | 1 | 1998 | 1187 | 0.010 |
Why?
|
Heart | 1 | 1966 | 4467 | 0.010 |
Why?
|
Molecular Biology | 1 | 1997 | 596 | 0.010 |
Why?
|
Specialties, Surgical | 1 | 1998 | 391 | 0.010 |
Why?
|
Proteomics | 1 | 2006 | 3638 | 0.010 |
Why?
|
Histamine Antagonists | 1 | 1993 | 93 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9438 | 0.010 |
Why?
|
Lysine | 2 | 1978 | 1007 | 0.010 |
Why?
|
Automation | 1 | 1995 | 584 | 0.010 |
Why?
|
Gadolinium | 1 | 1998 | 952 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1998 | 1072 | 0.010 |
Why?
|
Uridine | 1 | 1973 | 146 | 0.010 |
Why?
|
Breast Self-Examination | 1 | 1992 | 34 | 0.010 |
Why?
|
Tourette Syndrome | 1 | 1975 | 379 | 0.010 |
Why?
|
Carrageenan | 1 | 1992 | 67 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1973 | 668 | 0.010 |
Why?
|
Malpractice | 1 | 1997 | 572 | 0.010 |
Why?
|
Ventricular Function, Left | 2 | 1995 | 3670 | 0.010 |
Why?
|
Threonine | 1 | 1973 | 279 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1976 | 547 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 1973 | 467 | 0.010 |
Why?
|
Postmenopause | 1 | 2001 | 2461 | 0.010 |
Why?
|
Aminoquinolines | 1 | 1992 | 109 | 0.010 |
Why?
|
Receptors, Somatostatin | 1 | 1992 | 129 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8642 | 0.010 |
Why?
|
Peptides | 2 | 1981 | 4409 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1995 | 845 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 1992 | 231 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1982 | 5524 | 0.010 |
Why?
|
Sex Distribution | 1 | 1997 | 2297 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1999 | 1403 | 0.010 |
Why?
|
Craniocerebral Trauma | 1 | 1976 | 482 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 1955 | 415 | 0.010 |
Why?
|
Internship and Residency | 2 | 1993 | 5788 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2804 | 0.010 |
Why?
|
Sympathectomy | 1 | 1991 | 89 | 0.010 |
Why?
|
Light | 1 | 1977 | 1374 | 0.010 |
Why?
|
Complement Factor B | 1 | 1950 | 72 | 0.010 |
Why?
|
Kidney | 1 | 1966 | 7186 | 0.010 |
Why?
|
Smoking | 1 | 1987 | 8987 | 0.010 |
Why?
|
Molecular Weight | 1 | 1973 | 2255 | 0.010 |
Why?
|
Ultrasonography | 1 | 1984 | 5985 | 0.010 |
Why?
|
Myocardium | 1 | 1963 | 4776 | 0.010 |
Why?
|
Biological Transport | 1 | 1975 | 2118 | 0.010 |
Why?
|
Temperature | 1 | 1977 | 2206 | 0.010 |
Why?
|
Rh-Hr Blood-Group System | 1 | 1950 | 65 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1974 | 455 | 0.010 |
Why?
|
Antibody Formation | 1 | 1955 | 1402 | 0.010 |
Why?
|
Globus Pallidus | 1 | 1971 | 253 | 0.010 |
Why?
|
Chest Pain | 1 | 1997 | 1114 | 0.010 |
Why?
|
Genomics | 1 | 2006 | 5720 | 0.010 |
Why?
|
Radiation Dosage | 1 | 1978 | 1928 | 0.010 |
Why?
|
Personnel Staffing and Scheduling | 1 | 1993 | 501 | 0.010 |
Why?
|
Ligands | 2 | 1991 | 3282 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1977 | 1226 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 1995 | 824 | 0.010 |
Why?
|
Clone Cells | 1 | 1973 | 1692 | 0.010 |
Why?
|
Nasal Mucosa | 1 | 1992 | 373 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1994 | 1686 | 0.010 |
Why?
|
Oxidoreductases | 1 | 1991 | 424 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2005 | 5535 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1997 | 1990 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16689 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 1988 | 143 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1971 | 880 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1971 | 514 | 0.010 |
Why?
|
Social Class | 1 | 1997 | 1999 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4554 | 0.000 |
Why?
|
Dietary Fiber | 1 | 1992 | 760 | 0.000 |
Why?
|
Fasting | 1 | 1994 | 1593 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2001 | 3327 | 0.000 |
Why?
|
Health Behavior | 1 | 1999 | 2636 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1975 | 2924 | 0.000 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4042 | 0.000 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 1998 | 1414 | 0.000 |
Why?
|
Wakefulness | 1 | 1994 | 1245 | 0.000 |
Why?
|
Central Nervous System Diseases | 1 | 1971 | 518 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1988 | 552 | 0.000 |
Why?
|
Electroshock | 1 | 1986 | 122 | 0.000 |
Why?
|
Nutrition Assessment | 1 | 1990 | 723 | 0.000 |
Why?
|
Cell Aggregation | 1 | 1966 | 244 | 0.000 |
Why?
|
Jaw | 1 | 1986 | 96 | 0.000 |
Why?
|
Creatinine | 1 | 1971 | 1919 | 0.000 |
Why?
|
Angiotensin II | 1 | 1989 | 881 | 0.000 |
Why?
|
Canada | 1 | 1990 | 2065 | 0.000 |
Why?
|
Medulla Oblongata | 1 | 1986 | 243 | 0.000 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1975 | 2942 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1677 | 0.000 |
Why?
|
Sensory Thresholds | 1 | 1986 | 391 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1971 | 1813 | 0.000 |
Why?
|
Parathyroid Hormone | 1 | 1971 | 1801 | 0.000 |
Why?
|
Bucladesine | 1 | 1984 | 121 | 0.000 |
Why?
|
Patient Care Planning | 1 | 1989 | 921 | 0.000 |
Why?
|
Pedigree | 1 | 1971 | 4644 | 0.000 |
Why?
|
Cell Membrane | 1 | 1973 | 3748 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1990 | 9959 | 0.000 |
Why?
|
Concanavalin A | 1 | 1982 | 191 | 0.000 |
Why?
|
Hindlimb | 1 | 1984 | 504 | 0.000 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1984 | 821 | 0.000 |
Why?
|
Quipazine | 1 | 1981 | 6 | 0.000 |
Why?
|
Counseling | 1 | 1990 | 1523 | 0.000 |
Why?
|
Bone Density | 1 | 1994 | 3468 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1982 | 1162 | 0.000 |
Why?
|
Education, Medical | 1 | 1993 | 1721 | 0.000 |
Why?
|
Hemorrhage | 1 | 1993 | 3461 | 0.000 |
Why?
|
Microchemistry | 1 | 1980 | 57 | 0.000 |
Why?
|
Electrochemistry | 1 | 1980 | 145 | 0.000 |
Why?
|
Multiple Sclerosis | 1 | 1975 | 3079 | 0.000 |
Why?
|
Prostaglandins F | 1 | 1980 | 81 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1980 | 172 | 0.000 |
Why?
|
Thromboxane A2 | 1 | 1980 | 92 | 0.000 |
Why?
|
HeLa Cells | 1 | 1966 | 3128 | 0.000 |
Why?
|
Social Support | 1 | 1990 | 2118 | 0.000 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1975 | 3658 | 0.000 |
Why?
|
5-Hydroxytryptophan | 1 | 1979 | 32 | 0.000 |
Why?
|
Phenylalanine Hydroxylase | 1 | 1979 | 30 | 0.000 |
Why?
|
Weight Loss | 1 | 1990 | 2622 | 0.000 |
Why?
|
Cardiology | 1 | 1989 | 1668 | 0.000 |
Why?
|
p-Hydroxynorephedrine | 1 | 1976 | 1 | 0.000 |
Why?
|
Pactamycin | 1 | 1976 | 2 | 0.000 |
Why?
|
p-Hydroxyamphetamine | 1 | 1976 | 3 | 0.000 |
Why?
|
Polynucleotides | 1 | 1976 | 35 | 0.000 |
Why?
|
Poly U | 1 | 1976 | 10 | 0.000 |
Why?
|
Consanguinity | 1 | 1979 | 454 | 0.000 |
Why?
|
Chromatography, Liquid | 1 | 1980 | 976 | 0.000 |
Why?
|
Muscle, Smooth | 1 | 1980 | 934 | 0.000 |
Why?
|
Triticum | 1 | 1976 | 86 | 0.000 |
Why?
|
Precancerous Conditions | 1 | 1983 | 975 | 0.000 |
Why?
|
Pregnancy | 1 | 1997 | 29144 | 0.000 |
Why?
|
Tyramine | 1 | 1975 | 52 | 0.000 |
Why?
|
Ascorbic Acid | 1 | 1979 | 651 | 0.000 |
Why?
|
Chromatography | 1 | 1975 | 206 | 0.000 |
Why?
|
Growth Hormone | 1 | 1978 | 705 | 0.000 |
Why?
|
Apomorphine | 1 | 1975 | 150 | 0.000 |
Why?
|
Infant | 2 | 1979 | 35136 | 0.000 |
Why?
|
Mathematics | 1 | 1975 | 728 | 0.000 |
Why?
|
Solvents | 1 | 1975 | 302 | 0.000 |
Why?
|
Amphetamine | 1 | 1975 | 225 | 0.000 |
Why?
|
Infarction | 1 | 1975 | 244 | 0.000 |
Why?
|
Visual Acuity | 1 | 1982 | 2530 | 0.000 |
Why?
|
Aldosterone | 1 | 1978 | 877 | 0.000 |
Why?
|
Virulence | 1 | 1955 | 1333 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1984 | 12026 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1978 | 1826 | 0.000 |
Why?
|